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INTRODUCTION 
Studies conclusive of the role of manganese in 
normal metabolism have been possible only in re c ent years 
due to previou s non-availability of pr ecise quant i tat ive 
techniques . N eutr on acti vat i on ana lysis utilization has 
made possible measurement of as little as 3 x 10-5 ug/ml 
with 10 perc ent precision ( Cotz ias, 1958). 
The importance of s tu dying manganese involves its 
essentiality as a nutrient and its ant agon ism and i nte r­
relations with other essential dietary co mponent s . 
Manganese was first shown to be ess enti a1 for 
plant g rowth by McHargue (1923). Weinber9 (1964) found 
that bacteria require manganese for growth, for culture 
longevity, and to synthesize antibiotics, bact erioph age , 
protective anti gen s , several enzy mes and endospores. No 
other metal would satisfy this requirement. Underwood 
(1971) s tated that manganese was essential to poultry to 
prevent perosis and nutritional chondrodystrophy. It was 
neces sa ry in m amma ls for normal growth and re produc tive 
functi on. 
Specific biochemical roles for manganese have be en 
found. P yruvate carboxylase acti v ity has been shown to 
depend up on manganese (Scrutton, Utler and Mildvan, 1966). 
Leach and M uenster (1962) demonstrat ed its essentiality in 
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mucopo lys accharide syn the s i s . Eve r s on an d Shrader (1968) 
discl o s ed that man ganese had a rol e in g luco s e  util iza­
tion o 
Mangan e s e  has been found bound within e rythr ocytes 
and wa s thou ght to have a r o l e  in porphyr in me tabo l i sm 
(Bor g  and C otzias, 1958). High dietary intake of man g a­
nese in te rferes with hemoglobin formation (Hartman, 
Matrone an d Wis e, 1955; Matrone, Har tman an d Claw s on, 
1959; Cunnin gham, Wi s e  and Barrick, 1966). 
Effects of man gan e s e  defici ency on deve l o ping 
fetuse s have been well documente d (Ever son, 1970; 
Underwood> 197l)L H0wever� effects of high m�ternal 
manganese level s alterin g fe tal eryth�opoiesis have n o t  
been reportedo 
Underwoo d  (1971) s tr es s e d  the significance o f  the 
dietary man ganes e:i ron ratio. Sato and Murata (1932) have 
shown tha t co l o strum milk contain s much more mangane se 
than does normal milk, the fir st sample after parturition 
bein g especia l ly higho The s e  findin g s  raise the que stion 
of man ganese impor tance in fe tal developmen t, especiall y  
i n  e rythropoie s i s whe r e  iron i s  known to be of importance. 
The objectives of this study are as foll ows: 
a .  to de�e rmine whether man gane s e  is tran sporte d acr o s s  
the p l acenta again s t  a concentration g radien t a s  is i r on 
(Larkin, Wein traub an d Cro sby, 1970); bo to ascer tain if 
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high maternal blo o d  man ganes e  levels affect fetal eryth­
ropoiesis; c. to observe leukocyte formation alter ation; 
d. to inve stiga te whether fe tal o r ganogenesis i s  affected. 
Cer tain parameter s of bo th maternal and fetal 
fun c tions were me asured . Maternal red blood cells (RBC), 
white b l oo d  cell s ( WBC), packed cell volumes (PCV), hemo­
gl obin l evels, reticulocytes, white b l ood cell differen­
tials, mean corpu scular hemo g l obin ( MC H), mean corpu scular 
volume (MCV), mean corpuscular hemo globin concen t ration 
( MCHC) , R BC iron and man g anese an d plasma iron and mangan­
ese were compared. Fetal compari sons included RBC, WBC, 
Pcv, hemoglobin, reticulocytes, MCH, MCV, 11CHC, RBC iron 
an d man ganest, plasma iron and man ganese and o rgan weights 
of l iver, heart, lun g  and kidneys. 
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REVIEW OF LITERATURE 
Metabolism 
Manganese absorption has been studied extensively, 
especially in relation to absorption of other metals. 
Britton and Cotzias ( 1966 ) found that manganese was ab­
sorbed in proportion to the amount presented. They 
concluded that turnover depends extensively on dietary 
concentration. Pollack et al. (1965) determined absorp­
tion of manganese, cobalt and iron to be increased in iron 
deficient rats and attribute this to the similar chemistry 
of these elements. Their ionic radii are similar, and 
they coordinate with six ligands and form octahedral 
complexes. 
However, Sahagian, Harding-Berlow and Perry (1967), 
using an in vitro perfusion �ethod, described transmural 
movement of cobalt and manganese to be very rapid with 
little tissue retention and iron and zinc movement to be 
very slow with relatively high tissue retention. 
Manganese fed to rats at levels of 500 or 1000 
parts.per million (ppm) was found to depress iron absorp­
tion (Hansard et al., i960) . These authors inferred that 
manganese interferes with iron absorption to a greater 
extent than with iron utilization. Working with iron 
deficient animals, Forth ( 1970) found increased cobalt, 
manganese and zinc absorption along with iron and noted 
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an apparent competition. 
Further, Lassiter, Morton and Miller (1970) have 
shown that more parenterally administered radiomanganese 
was excreted when rats were on a high calcium diet. High 
dietary phosphorus appeared to have no effect on parenter­
ally administered manganese retention. Schaible and 
Bandemer (1942) a n d  Wilgus and Patton (1939) had earlier 
shown this effect in birds, but their conclusion was based 
on adsorption of manganese by phosphates and carbonates in 
vitro, an effect thought to reduce soluble manganese. 
· Cotzias and Papavasiliou (196 4) demonstrated 
several routes available for manganese excretion, all 
linked to the gastrointestinal canal. They further demon­
strated that while the liver controls manganese flux 
following ordinary metabolic demand, the pancreas does so 
under extraordinary loads. Britton and Cotzias (1966 ) 
fed excess manganese and found the metal being absorbed 
in proportion to the amount presented. Their conclusion 
was that metabolism of this metal is regulated by its 
excretion rather than by both regulated absorption and 
excretion. 
Papavasiliouj Miller and Cotzias (1966 ) contrasted 
intestinal excretion of manganese with renal excretion 
and concluded that the kidney excretes negligible amounts 
even during jaundice and after manganese loadingo They 
traced the route after absorption to the liver where man­
ganese becomes localized in mitochondria followed by 
biliary discharge. 
Rapid excretion of intravenously injected radio­
manganese was found in bile, reaching a peak a few minutes 
after injection (Bertinchamps and Cotzias, 1968). Subse­
quent electrophoretic studies showed patterns with several 
peaks suggesting several chelates to be present. 
An investigation determining the excretion sites 
in the.gastrointestinal tract showed much higher amounts 
excreted by the duodenum and jejunum than by the terminal 
ileum (Bertinchamps, Miller and Cotzias, 1966). Cephalad 
segments responded more quickly to manganese loading 
suggesting these to be homeostatic end organs auxiliary 
to the liver. 
Mahoney and Small (1968), investigating the biolog­
ical half life of radiomanganese, found manganese disap­
pearance from the body to be described by a curve having . 
two exponential components. An average of 70 percent of 
injected material was eliminated by a 0slow" pathway with 
an average value of 39 days. The half time for the "fast" 
component was four days. A low manganese intake increased 
the slow pathway percentage to 90 days. 
It was shown by Hughes, Miller and Cotzias ( 1966) 
that cortisol affects manganese metabolism, but the 
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precise adrenal role rem ains uncertain. However, these 
authors feel syndromes in man similar to experimental 
manganese defic iency i nduceabl e by these hormones should 
be �nvestigated. 
Subcellular distribution of iron and manganese has 
been expl ored and has been found to be complementary. 
Nuclei and mitochondria were found to contain the highest 
manganese concentrations and lowest iron concentrations 
( Thiers and Vallee, 1957). 
·Ferrante (1961) stated that enzyme activation in 
cellular elements may be the prime function of manganese 
based on information indicat ing activation of a variety 
of enzymes by manganese in vitroo However, Cotzias and 
Papavasiliou (1962 )  indicated the existence of more than 
one chemical species of manganese in the body and argued 
that it was highly problematical whether in vitro mangan­
ese additives could duplicate ex clu s ive l y such highly 
divergent natural chemical forms. 
Scrutt on, Utler and Mildvan (1966) dem on st rated 
manganese in purified pyruvate carbox ylase and quantita­
tive analysis revealed 2.5 to 4.3 moles of manganese per 
mole of enzyme. Utilizing radiomanganese, good correla­
tion was obtained between radioactivity and enzymatic 
activity. Manganese release occurred only after irrevers­
ible enzyme de naturation. 
7 
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Underwood (1971) presented evidence for reduction 
of liver arginase in manganese deficient rats and rabbits. 
However, even though arginase activity was shown to 
increase in vitro, he was doubtful of in vivo activation 
by manganese. 
Hypoglycemia has been shown to be an effect induced 
by manganese in an unusual diabetic (Rubenstein, Levin and 
Elliott, 1962). Manganese action on the pancreas was the 
favored explanation, for the effect was abolished follow­
ing pancreatectomy. Manganese deficient guinea pigs 
demonstrated aplasia of all pancreatic cellular components 
with a resultant diabetic glucose tolerance curve. These 
effects were reversed by manganese administration (Everson 
and S chrader, 1968; Everson, 1970). 
Manganese was first shown to be necessary for car­
tilage mucopolysaccharide synthesis by Leach and Muenster 
(1962). Grebner, Hall and Neufeld (1968) later demon­
strated manganese catalysis of glucosamine-serine link­
ages. Everson (1970) demonstrated significant differences 
of acid mucopolysaccharides (AMPS) in cartilage of control 
and deficient guinea pigs. Depressed AMPS content of 
chicken egg shells has been shown with low manganese in­
take (Longstaff and Hill, 1970). Reduced epiphyseal car­
tilage mucopolysaccharide and hexosamine in lambs on low 
manganese diet has been demonstrated (Lassiter et al., 
1970). 
Manganese has been implicated in lipid metabolism. 
Documentation for manganese-choline interaction has been 
presented, although the author states this to be little 
understood (Underwood, 1971). Curran (1954) presented 
evidence for manganese stimulation of hepatic cholesterol 
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and fa t ty acid syn thesis in rats, while Amdur, Rilling and 
Bloch (1957) found that manganese was necessary for con-
-
version of mevalonic acid to squalene by mevalonic kinase. 
Studying iron deficient subjects, Mahoney and Small 
(1968)
. suggested an in terrelation between manganese and 
iron metabolism. Experimental data presented by Titus, 
Cave and Hughes (1928) indicated that manganese added to 
milk-iron. diets produced quicker responses in hemoglobin 
building than non-supplemented diets. Beard, Baker and 
Myers (1931) demonstrated that iron supplemented with var-
ious trace metals, including manganese, enhances matura-
tion of erythrocytes. Myers and Beard (1931) stated that 
iron was essential in hemoglobin regeneration in nutri-
tional anemia , while copper, nickel , germanium, manganese, 
a rsenic, titan ium, zinc, rubidium, chromium, vanadium, 
selenium and mercury ac tion was probably catalytic. 
Working with lambs receiving high manganese supple­
ments, Hartman, Matrone and Wise (1955 ) discovered that 
hemoglobin levels were lower .. t han controls. This was 
lo· 
thought to be due to either interference with iron absorp­
tion, with hemoglobin formation or a combin ation. Cotzias 
(1958) suggested an indirect r o l e  o f  mang anese in hemato-
poiesis. 
Borg and Cotzias (1958) found a firmly bound m an­
g anese component in human and rabbit erythrocytes and 
suggested that mang ane se had a role in porphyrin metab­




Mn were found in 
red cell fractions of blood. They showed that the metal 
was noti-dialysable, non-exch angeable and not av ailable for 
chelation with disodium ethylenediamine tetraacetic ac i d 
(EDTA). 
Investigating manganese-iron an tagonism , Matrone, 
Hartman . and Clawson (1959) found high manganese supplements 
depre ssed hemogl obin formation, but high iron supplements 
reversed this effect. Howe ver, Cunningham, Wise and 
Barrick (1962) did not f ind any ef fect on hemoglob in for-
mation in c alves with high manganese supplements. 
Cunningham, Wise and Barrick (1966), in con flic t to their 
earlier fin dings, showed depressed hemoglobin levels in 
calv es fed man ganese in high levels. Equal amount s of. 
feed were given to all cal ves in the second study while 
� libitum fee ding characterized the first. 
Mackiewicz (1965a) state d that man ganese adminis­
tered to anemic rats had no influence on the course of the 
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anemia. However, in a subsequen t study, she found iron 
supplemented with manganese was more effective in its 
erythropoiet ic effect than iron alone (Mackiewicz, 1965b). 
Cotzias, Miller and Edwards (1966), searching for a 
manganese porphyrin, suggested that their experiments 
indicated the incorporation of stable manganese into the 
heme moiety of erythrocytes. Animals made anemic by 
bleeding or by i ron deficient diet increased the amounts 
of iro�, manganese and cobalt absorbed (Pollack et al., 
1965). 
McNary ( 1960 ) reported the presence of manganese 
in n eutrophils and eosinophils, but the concentration in 
other leukocytes or platelets has not been described. 
Arthrit i cs have been found to have high erythro­
cyte concentrations of manganese with slow turnover rates. 
A. correlation w i th abnormalities of rnucoprotein and muco­
polysaccharide metabolism exhibited by arthr�tics was 
suggested by the se authors ( Cotzias et alo, 1968)0 
Meiri and Rahamimoff (1972) have shown th at man­
ganese ions inhibit neuromuscular transmission. Alter­
ations in manganese concentrations have been assoc i ated 
with certain neurological disorders ( Mena et al., 1967, 
1969; Cotzias et al., 1968). The po ssibi l i ty does exist 
that certain synapses may possess a high sensitivity for 
manganese ions. 
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Newl and and Davis (1961) , feeding high level s of 
m angane se to gravid gil ts, found no s ignifican t  d ifferen ce 
in fe t a l  growth , al though fe tu se s from high mang ane se 
level sow s  did con t ain high e r  mangane se concen tra t i on s. 
H an s ard (1970) found tha t  m ang anese accumula ted in fe tu ses 
during the final tr imes tero G am ble e t  a lo (1971) , 168 
h f t  . . t· 54M f d 2 5 7 t f th ours a- er inJec ing n, oun • percen o e re-
tained me tal in the concep t i on produc t s, 87 percent o f  
wh i ch wa s i n  the develop ing fe tuse s. 
Pl acen t a l  m ang anese tran spor t mech ani sm s h ave yet 
to be e lucid a te d, but iron w a s  found to be tran spor ted to 
pldcenta cells Ly tran sferrin- iron complex. Placental 
cells bind the complex, u til ize the iron , and rel e as e  the 
transferrin. The se cel ls were able to take up i ron 
against concen tration gradien t s  and transpor t  it in a 
unidirectional vectoria l  proces s ( L arkin , Weint r au b  and 
Cros by , 1970). 
Level s and S toraqe 
Tip ton, S tewart and Martin (1966) , in a 30 d ay 
study of two norm al h um an subjec ts, found ave r a g e  d aily 
in take s o f  mangane se were 4.39 mg and 3o4 5  mg. The 
am ount s  found in fece s were 1.21 mg and 2.59 mg, leaving 
a balance of 3.45 and Oo54 mg. Underwood 
(1971) reporte d  
that bones, liver , kidney s , pancrea s  and p i tui ta ry gl and 
carried higher manganese concentrations. Skeletal mus cles 
were#among the lowest. Cotzias (1958) stated that a 70 kg 
man contains 12 to 20 mg man ganese. Schroeder, Balassa 
and Tipton (1966) found that body distribution of mangan­
ese was wide with particular organs having characteris tic 
concentrations which varied little within or among species 
or with ageo Underwood (1971) further noted that skeletal 
manganese does n ot constitute an important mobilizeable 
s tore. 
Values reported in the literature for blood mangan­
ese content vary widely. Values obtained from early 
studies rcview_d by Ferrante ( 1961) ranged f�om 284 to 
13 ug/100 ml. Later work using more accurate neutron 
activation analys is reported by Cotzias, Miller an d  
Edwards (1966) and Papavas iliou, Miller and Cotzias (1966) 
found 8.44 ug/liter and 9.84 ug/liter r espe ctively. This 
was partitioned to obtain values of 1.42 ug/liter for 
s erum an d  23.57 ug/liter for erythrocytes. 
Sawhney and Kehar (1961) investigated manganese 
content of blood from 12 bullocks and found 0.0180 to 
0.0184 mg/100 ml. This was in contrast to neutron activa­
tion analys is of manganese in rabbit blood by Papavasiliou 
and Cotzias (1961) who found only 6.85 ug/liter. 
Conflicting data exists concerning liver s torage 
of mangan ese. Underwood (1971) reported work of s everal 
279489 
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investigators showing no reserve stores of manganese in 
liver tissue, but Howes and Dyer (1971) demonstrated that 
newborn calves preferentially utilized hepatic tissue to 
store manganese. 
Hughes, Miller and Cotzias (1966) showed that man-
ganese was shifted from liver to carcass tissues f ollowing 
administration of glucocorticoids or adrenocorticotropic 
hormone. They further demonstrated that manganese concen­
trations were not altered following adrenalectomy except 
in animals receiving diets supplemented with high level 
manganese. 
52 
Anke and Groppel (1970) fed Mn to hens and co·1s, 
finding that most of this isotope was transported to bones 
and ovaries for storage, but a transient accumulation was 
found in liver, feathers, skeletal muscle and kidneys. 
Requirements 
Manganese r equirements depend upon species, criter-
ia of adequacy, chemical form and other constituents in 
the diet (Underwood, 1971). Birds are known to have a 
higher requirement than mammals. 
Wachtel, Elvehjem and Hart (1943) found that 0. 1 
to 0.2 ppm manganese added to a milk diet was inadequate 
for growth in mice, rats and rabbits. High phosphor us in 
relation to calcium increases the requirement. 
15 
Def i c iency 
Everson (1970) found th at deficiency affec t s grow th, 
viability of offspring , skeletal development, coordin ati on , 
fert i lity and arginase activityo Underwood (1971) stated 
that these manifestations were simi lar in all spe6ies, 
although expression varieso His review of the li ter ature 
fai l e d  to produce unequivocal ev idence of uncompl ica ted 
de f iciency in grazing livestock, although deficiency does 
occur natura l ly in certain diets fed to pigs and p oultry o 
Lassiter et al. (1970) found that e arl y weaned 
lambs receiving a pu ri fie d diet w i th less th an one ppm 
manganese tor five months exhibited bone changes demon­
strated by tioia s which were lighter, shorter, h a d  r educ e d  
volumes and lower bre aking stren g th. Lon gstaff and H ill 
(1970), feed ing l ow-manganese-high-phosphorus d i e ts to 
chickens observed no changes in sh el l m a tr ix as a whole 
bu t a markedly depressed AMPS content of rn atrixo 
Matern al d i e ts def icient in manganese r esult e d  in 
increased inc i de nce o f  s t illbir ths with many young failing 
to surv i ve more than thre e or four days in gu inea p i gs 
(Everson, 1970)0 In a study utilizing goats r e c eiving low 
manganese diets, 23 percen t  of the tre atmen t animals 
aborted, while no abortions occurred in contro l groups 
(Anke and Groppel, 1970). 
16 
Off spring of manganese deficient guinea pigs s tud­
ied by E verson (1970) had failure of normal otolith devel-
opment which was not correctable by manganese supplements. 
This developmental failure resulted in ataxia in both 
poul try and mammals (Underwood, 1971) 0 
Anke and Groppel (1970) found that deficient female 
goats had later estrus, weak symptoms of estrus, and r�-
-
quired more inseminations to become pregnant. Underwood 
(1971) cited early work demonstrating defective ovulation, 
testicular degeneration and increased infant mortality in 
deficient animals. However, there was no indication of 
the precise locuso Manganese was not normally present in 
high concentration in gonadal tissue. 
Toxicity 
Cotzias (1958) reported natural manganese poisoning 
occurred among miners working with manganese ores. 
Characteristics of chronic poisoning were locura manganica 
which resembled schizophrenia and permanent neurologic 
(extrapyramidal) disorder similar to Parkinson's disease. 
Mode of entry was via the lungs and gastrointestinal 
tract. 
Gallup and Norris (1939) reported rat growth was 
unaffected by 1000 to 2000 ppm dietary manganese and hens 
tolerated 1000 ppm. Grummer et alo (1950) stated that 500 
ppm manganese in diets of growing pigs retarded growth and 
17 
depressed appetite . Cunningham et al. (1966) fou nd no 
effect in calves with 820 ppm, but depressed feed intake 
and weight gain with 2460 and 4920 ppmo Increased mangan­
ese caused a small but significant depression of hemoglo­
bin forrnation o Therefore, manganese rates in the lower 
group of toxic trace elernentso 
Underwood (1971) indicated that the manganese:iron 
dietary ratio had a wider significance than was common ly 
thought. Matrone, Hartman and Clawson (1959) found that 
1250 and 2000 ppm manganese caused depressed hemoglobin 
synthesis in rabbits an d baby pigs, but was reversed by 
400 ppm iron supplements. They assumed an interfe�ence 
wi th iron absorption rather than with hematopoiesis. 
Mena et al. (1970) suggested that chronic mangan­
ese poisoning could injure the dopaminergic components of 
t he extrapyramidal system in a manner paralleling 
Parkinson's syndrome. Patients receiving L-Dopa 
(L-Dihydroxyphenylalanine) showed striking reduction or 
d isappeara nce of rigidity and hypokinesia, marked imp rove­
ment of postural reflexes and restitution of balance. 
EXPERIMENTAL PROCEDURE 
Experimental Animals 
T wen ty-one Du tch-belt e d  female rabbits wei gh ing 
1950 to 2650 grams we r e  util ized in these investigations. 
All were acti ve, alert and apparently di se ase free. Each 
animal was penned ind ividually in stainless steel 
batteries and provided with water and pe l l etize d  rabbit 
ration1 ad libitum. Animals wer e  bre d to Dutch-b e l ted 
males. Each animal was as signe d  to eithe� a s�line con-
trol group (Group I) or to one of two tre atment groups 
( Groups II and III). 
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Stock treatment solution was prepared f rom research 
grade Mnc12-4 H20 and doubl e-distilled deionized water to 
con tain 2.0 mg Mn+2/ml with correction made for water of 
hydration� GroOp I (control) does received 10 ml 0 . 8 5% 
NaCl , Group II received 2.5 mg/Kg body weight in 10 ml 
solution and Group III rec ei ved 10 mg/Kg bod¥ we i gh t in 
.. 
10 ml solution. The inj ec tions were administered intra-
peritoneally imme di a te ly following withdrawal of pre­
trea tment blood sampleso 
In order to prevent contamination with metals to be 
measured, al l glassware was thoroughly washed, rins e d  
twice in double-distil l e d  �eionized water, soaked in 3N 
l
Ralston Purina co., Sto Louis, Missouri, 63188. 
HCl for four hours, rinsed in double-distilled deionized 
water and oven-dryed. Syringes and needles were treated 
as glassware exc e pt for only a brief rinse in 3N HCl. 
All doe blood collections were accomplished by 
cardiac puncture employing heparini zed glass syringe s  and 
18-gauge ne edles. Samples were immedia tely placed in 
glass tubes containing 50 0 units so?ium heparin and stop ­
pere d. Approximately 12 ml of blood was withdrawn . Pre­
treatment samples were collected on Day 22 to Day 24 of 
pre gnancy . Final samples were obtained on eithe r Day 29 
or Day 30 of pregnancy prior to sacrifici n g. 
Anl1ilals w�re sacrificed on Day 29 or Day 30 of 
pregnancy by massive cardiac air embolism .  The abdomen 
was immediately opene d and fetuses removed , tagged and 
placed in a stainles s steel container suspended in a 
second container containing warm water to prevent death 
by.exposure before blood samples coul d be collected. 
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Blood samples we re obtained from fetuses by sev­
ering the carotid artery and collecting the blood in glass 
tubes contai ning 50 0 units sodium heparin and then stop­
pered� It was found that even though the blood sample was 
small (approximately 2 ml) large amounts of anticoagulant 
were necessary to prevent coagulation. The fetuses were 
then disected as outlined by Thibodeau Ci967). The fol­
lowing organs were remo ved: left lung; h eart ;  right 
20 
kidney ; and liver. These organs were weighed on a 
Sartorius balance sensitive to one ten-thousandth gram. 
Hemogram Determinations 
Red and white blood cells were enumerated in dupli­
cate utilizing the Coulter Coun te r  Model F2 • Dilutions 
3 were prepared with a Coulter Counte r Dual-Diluter using 
Isoton4 as the diluent and Zap-Isoton5 as a lysing agent. 
Red cell counts were corrected employing the Coulter 
Counter Coincidence Correction Chart.6 
Dup licate packe d cell volumes were determined em­
ploying the microhematocrit technique . 7 Duplicate hemo-
globin determinations were obtained by the cyanmethemo ­
globin method8 using HycelR hemoglobin standard9, and a 
Beckman Grating Sp e ctrophotometer Model DB-G.10 
2 
Coulter El ectronics, Inc., Hialeah, Florida. 
3 Cou l ter Electronics, Inc., Hial eah , Florid a. 
4 Coulter El ectronics, Inc., Hialeah, Florida. 
5 Coulter Diagnostics, Ince, Miami Springs, Florida . 
6 Coulter Electronics, Inc., Hialeah, Florida. 
7
c1ay Ad ams, Inc., New York, New York, 10010. 
8
cy anmethemoglobin Determinations, Hycel, Inc., 
Houston, Texas, 77036. 
9 . Hycel, Inc., Houston, Texas, 77036. 
lO
Beckman Instr�ments, Inc., Fullerton, California, 
92634. 
The Wintrobe indices, mean corpuscular hemoglobin 
( MCH) , mean c orpuscular volume ( MCV) and mean c orpuscular 
hemoglobin concentration (MCHC) we re calculated using the 
following f ormulae: 
MCH (micromicrograms) 
MCV (cubic microns) 
= g_hemoglobin/100 ml blood x 10 
erythrocytes, million/cubic mm 
= packed cell volume x 10 
erythr ocytes, million/cubic mm 
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MCHC ( percent) = g hemoglobin/100 ml blood x 100 
packed cell volume, percent 
All hemogram parameters o f  both doe and fetuses 
were completed within four hours a fter obtaining the blood 
samples. At this time blood smear slides were prepared 
and stained with methylene blue for reticulocyte determi-
nations according to the procedure of Brecher (1949). One 
thousand erythrocytes were counted utilizing an ocular 
grid and oil immersion lens. Blood smear �lides were pre-
pared for leukocyte di f ferent ial determinations us ing 
Wright's stain in th e pro�edure outlined by Davidsohn and 
Nelson (1969). Two hundred leukocytic cells were coun ted 
employ ing an oil immersion lens. 
� and Manganese Determinations 
Fetal blood was pooled by litter f or iron and man­
ganese determinations. Pre-treatment and final doe blood 
samples were analyzed individually. Red blood cell s and 
plasma were separated and prepared for analysis according 
2 2  
to the meth od re commended b y  Wade ( 1 97 2 ) . S amp l e  iron and 
manga nese w a s  d ete r mined emplo y ing a P e rk in -E l me r  A tomic 
Ab s orp t i on S p e c troph o tome t e r, Mode l 3 03 .
1 1 
S tand a r d s  
u t i l i ze d  f o r  iro n  w er e  1 ,  5 ,  1 0 ,  1 5 ,  2 0  and 2 5 pp m .  Ma n-
gan e s e  sta n dard c oncen tr at i on s were O o l, 0 . 2  and 0 . 5 ppm . 
I n te rpo l a t ed va l u e s for ca lcula t i ng s ample con centrati ons 
were ob t ai n e d using an Olive t t i  U nder wood Pro gramma 1 0 1 1 2  
w i th th e f ollo w i ng formu la :  
1 y ( x ) = x
0
- x1 
( yO -y l ) x-yox1+y 1 xo 
Where x 0 a nd 
x
1 e qual s t an dard c onc e n t r a t i on s ,  y0 and y 1 
equal s ta ndard ab s orbance values and x a nd y equ a l samp le 
co ncentr a ti o n  a nd ab s orban c e , r e sp e cti ve l y .  
� Analysis 
An a l y s i s o f  d a t a  w a s  co mp l et ed u s in g  an O live t ti 
Underw ood Programma 1 0 1 .  T he analy s is of var i an c e  w a s  
us ed a s  the t e s t · o f s tatis t ical s ig n if ican ce f o r  a l l d a t a . 
Red b lo od cells, w hite blo o d  cel ls, p acked c e l l vo l ume s ,  
hemog l ob i n  l e ve l s ,  re ticu l ocy t e s , white b loo d c e l l  d i f f e r -
ent i als , MC H , MCV , MC HC , r e d  blood ce l l  i r on a nd ma nganes e  
and p l a sma iro n  a nd man g an e se wer e  comp are d f o r  does . · 
Fe tal comp a ri so ns w er e  mad e  f or re d blood ce l l s ,  w hi te 
1 1
P erkin-E lmer Corp . ,  N o rw a l k , Conne c ticut .  
1 2
0 1 ive tti U nd erwo o d ,  O ne P ark Avenue , N ew York , 
New York , 1 0 0 16 .  
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b l ood ce l l s ,  p a c k e d  c e l l vo lume s , hemog l obin , r e t i cu l o ­
cy te s , MCH , MCV , MCHC , red blood c e l l i r on and man g an e s e  
an d p l a sma i ron an d man g an e s e . Al so , we t we ights 0 £  fe t a l  
l i ve r , h e ar t , l e f t  l un g  a n d  r i g h t  k i dney w e r e  c omp are d  a s  
t h e  pe rcen t a ge o f  t o t a l  body we i gh t .  
Re su l t s o f  s t a t i s t i c al c omputation s are shown in 
tab l e s 1 and 2 o  
TABLE 1 .  ANALYS I S OF VARI AN CE FOR DOE DATA 
B a s i s  S ource d . f .  Sum o f  Me an 
S qu are s S qu ar e  
R e d  B l o o d  T r e a tmen t  5 6 . 0 7 7 1 . 2 1 5  
C e l l s  E r r o r  3 6 5 2 . 5 0 7 1 . 4 5 8  
T o t a l  4 1  5 8 . 5 8 4  
Whi te B l o o d  T r e a tmen t 5 1 8 5 6 . 4 4 4  37 1 . 2 8 8  
C e l l s  E r r o r  1 2 4 9 5 2 . 6 6 8  4 1 2 . 7 2 2  
T o t a l  1 7 6 8 0 9 . 1 1 2  
P ack e d  C e l l T r e a tmen t 2 2 0 5 9 5  1 . 2 9 8  
Vo lume E rror 1 8  1 4 5 . 7 1 4  8 0 0 9 5  
To t a l  2 0 1 48 0 31 0  
Hemo g l ob in T r e a tmen t 2 0 . 2 9 2  0 0 1 4 6' 
E rror 18 1 8 0 1 6 5  1 . 00 9 
To t al 2 0 1 8 . 4 5 8  
Re ticu l ocy te s T r e a tmen t 5 3 . 6 30 0 . 72 6  
E rror 3 6  3 2 . 0 8 8  0 . 8 9 1 
T o t a l  41 3 5 . 7 1 8  
M e an Co rpu s cu- Tre atmen t 5 4 2 . 6 8 7 8 . 5 3 7  
l ar Hemo g l ob in E r r or 3 6  2 8 5 . 9 7 4 7 . 9 4 3  
T o t a l  4 1  3 2 B . 661 
F R a t i o  
0 � 8 3 3 N S  
0 . 8 9 9
N S  
0 . 1 6 0
N S  
0 . 1 4 4
N S  
0 . 8 1 4
N S  
l . 0 7 4·NS 
f\) 
tf::> 
TABLE 1 CON T INUE D 
Bas i s  S ourc e 
Me an C o rpu scu- T r e a tmen t 
l ar Vo lume Error 
T o t a l  
Me an Corpu scu- T re atmen t 
l ar Hemo g l ob in Erro r 
Concen tr ation T o t a l  
R e d  B l oo d  C e l l  T r e a tmen t  
Mangane s e Error 
T o t a l  
P l a s ma Tre a tmen t 
Man g an e s e  E rror 
To t a l 
Red B l ood C e l l  Tre a tment 
I ron Err.or 
Total 




N t s ·  . f . t o i gn i  i c an . • 
d . f .  S um o f  
S qu are s 
5 1 4 2 . 4 0 8  
3 6  2 9 8 5 . 2 1 1  
4 1  3 1 2 7 . 6 1 9  
5 1 5 . 2 0 8  
3 6  1 2 3 . 9 9 9  
4 1  1 3 9 0 2 0 7  
5 2 6 . 5 8 4  
2 8  1 4 1 . 9 1 1  
3 3  1 6 8 . 4 9 5  
2 1 . 7 6 4  
1 7  1 0 5 . 4 4 4  
1 9  1 0 7 . 2 0 8  
2 8 1 . 1 1 7  
1 7  2 8 7 . 4 1 0  
1 9  3 68 . 52 7 
5 0 . 3 3 1  
3 3  1 . 5 3 9  
3 8 1 . 8 7 0  
·-
Me an F Ratio 
S qu are 
2 8 . 4 8 1  0 . 3 4 3N
S 
8 2 . 9 2 2  
3 . 0 4 1  0 . 8 8 2 N
S 
3 . 4 4 4 
5 . 3 1 6  l . 0 4 9 N S 
5 . 0 6 8  
0 . 8 8 2  0 . 1 4 2NS 
6 . 2 0 3 
4 0 . 5 5 9  2 . 3 9 9
N S 
1 6 . 9 0 6  
0 . 0 6 6  l . 4 2 1
N S  
0 . 0 4 6  
f\.) 
(.J1 
TA BLE 2 .  ANALYS I S  OF VARIANCE FOR F E TUS DATA 
Ba s i s  S ou rc e  d . f .  S um o f  Me an 
S qu ares S qu a r e  
R e d  B l oo d  Tre atmen t 2 0 . 3 1 7  0 . 1 5 8  
C e l l s  E rr o r  1 2 9 5 4 . 4 7 3  0 . 4 2 2 
T o t a l  1 3 1  5 4 . 7 9 0  
White B l o o d  Tre atme n t  2 1 9 8 ., 1 3 0  9 9 . 0 6 5  
C e l l s  E r r.or 1 2 9 48 7 . 5 2 7  3 . 7 7 9 
T o t a l 1 3 1  6 8 5 . 6 5 7  
P acked C e l l  Tr eatmen t 2 4 7 6 . 4 3 9  2 3 8 . 2 1 9  
Vo lume E r ror 1 2 9  3 5 5 2 . 0 8 2  2 7 . 5 3 5  
T o t a l  1 3 1  4 0 2 8 . 5 2 1  
I 
H e mo g l obin Tre a tmen t 2 1 9 . 7 5 9  9 . 8 7 9 
E r ror 1 2 9 2 4 6 . 9 6 7  1 . 9 1 4  
T o t a l  1 3 1  2 6 6 . 7 2 6  
Re ticu l ocy t e s T re atmen t 2 3 1 6 . 6 4 1  1 5 8 . 3 2 0  
E rror · 1 2 8  1 3 7 5 . 5 4 1  1 0 . 7 4 7  
T o t a l  1 3 0 1 6 9 2 . 2 8 2  
Me an Corpu s cu- Tre a tmen t 2 1 5 9 . 3 9 2  7 9 . 9 4 6 
l ar Hemo g l obin E r r o r  1 2 9  1 0 4 8 . 8 2 8 8 . 1 3 0  
T o t a l  1 3 1  1 2 0 8 . 7 2 0  
F R a t i o  
0 . 3 7 4
N S 
2 6 . 2 1 4 • • 
8 . 6 5 1 * * 
5 . 1 6 1 • • 
1 4 . 7 3 1 * *  
9 . 8 3 3 * • 
N 
(1) 
TABLE 2 CONTINUE D 
Ba s i s  S ource d . f .  Sum o f  
S qu are s 
Me an C orpu s c u - T re atmen t 2 3 0 3 8 . 1 0 4  
l ar Vo l ume E r ror 1 2 9  1 3 4 4 8 . 0 4 9  
T o t a l  1 3 1  1 6 4 8 6 . 1 5 3  
Me an Corpu s c u - T re a tmen t 2 1 5 . 1 5 6  
l ar He mo g l o b in E r ror 1 2 9  1 7 9 . 5 3 6  
Concen t r a tion T o t al 1 3 1  1 9 4 . 6 9 2  
Red B l oo d  C e l l  T re a tmen t 2 7 0 4 . 3 8 9  
Man g ane s e E rr o r  1 8  3 2 7 . 4 9 2  
T o t a l  2 0  1 0 3 1 . 8 8 1  
P l a s ma T r e a tmen t 2 1 8 . 6 4 8  
Man g an e s e  E rr o r  1 7  1 3 4 . 7 4 2  
T o t a l  1 9  1 5 3 . 3 9 0  
Red B l ood C e l l T r e a tmen t 2 1 1 0 . 7 6 6  
I ron E rro:r- 1 8  4 9 9 . 5 4 8  
To t a l  2 0  6 1 0 . 3 1 4  
P l a s ma I ron Tre a tmen t 2 0 . 1 6 5  
E r r o r  1 8  1 . 5 4 1 
T o t a l  2 0  1 . 7 0 6  
M e an 
S qu ar e  
1 5 1 9 . 0 5 2  
1 0 4 . 2 4 8  
7 . 5 7 8 
1 . 3 9 1  
3 5 2 . 1 9 4  
1 8 . 1 9 4  
9 . 3 L 4  
7 . 9 2 6  
5 5 . 3 8 3  
2 7 . 75 3 
0 � 0 8 3 
0 . 0 8 5  
F R a t i o  
1 4 . 5 7 1 * * 
5 . 4 4 7 • • 
1 9 . 3 5 8 * * 
l . 1 7 6
NS 
l . 9 9 5
N S  




TABLE 2 CONTINUE D 
B a s i s  S ou r c e  
T o t a l  Body T r e a tmen t 
We i g h t  E rr o r  
T o t a l  
Heart T r e atmen t 
E r ror 
T o t al 
Live r  T r e atme n t  
E r r o r  
T o ta l 
Kidney T r e a tmen t 
E r r o r  
To tal 
Lung T r e a tmen t 
E rror 
Total 
• • p  < . 0 1 . 
N SN o t S i gn i f i c an t . 
d . f .  Sum o f 
S quare s 
2 6 9 4 . 3 1 4  
1 3 5  6 8  �' 9 . 5 4 2  
1 3 7  7 5 7 3 e 8 5 6  
2 0. 2 5 9 
1 3 5  0 . 8 4 7  
1 3 7  1 . 1 0 6  
2 1 5 . 3 2 3  
1 3 1  7 0 . 7 6 9  
1 3 3  8 6 . 0 9 2  
2 0 . 1 1 4  
1 3 5  0 . 4 5 1 
1 3 7  0 . 5 6 5  
2 1 . 1 4 7  
1 3 5  3 . 5 4 2  
1 3 7 4 . 6 8 9 
Me an 
S qu are 
3 4 7 . 1 5 7  
50. 9 5 9  
0 . 1 2 9 
0 . 0 0 6  
7 . 6 6 1  
0 . 5 4 0  
0 . 0 5 7 · 
0 . 0 0 3 
0 . 5 7 3 
0 . 0 2 6 
F Rati o 
6 . 8 1 2 • •  
2 0 . 8 5 5 * * 
1 4 . 1 8 7 • * 
1 7 . 2 7 3 • • 
2 1 . 8 8 2 * * 
N 
ro 
RE SUL T S  AN D D I S CUS S ION 
An a l y s i s of var i an c e  w a s e mp l oy e d to e va l u a te 
tre a tmen t e f f e c t s o Re s u l t s  o f  th e s e an a l y s e s  ar e pre ­
s en ted in t ab l e s l an d 2o 
S i gn i f i c an t d i f f e r en c e s  cou l d  no t b e  s h own b e ­
twe en con t ro l  a n d  trea tmen t do e s o � ow e ver , b o th con t ro l  
and tre at men t grou p s  d e mon s t r a te d  d e c r e a s e d  p a c k e d  c e l l  
vo l ume s ,  h e mo g l obin an d re d b l ood c e l l  i ron d u r in g  the 
f i n a l  week o f  p r e gn an cy o E l e va t e d  b l ood vo l u me an d  i ro n  
s tora ge d e p l e t i on a re n o rma l phy s i o l o g i c a l  a l t e r at i on s 
du ri n g  p r e g n a n c y  wh i c h  a c c oun t f o r  th e s e ch an g e s ( Guy tort , 
1 971 ) .  
Red b l oo d c e l l en u me r a t i on s o f  fe tu s e s  in t r e a t -
men t g r o u p s  d i d  n o t  di ffe r s i gn i f i c an t l y f rom c on tro l s . 
Re t i c u l oc y t e c oun t s w e re e l e va te d  ( h igh l y  s i gn i f i c an t l y ) 
in t re a t men t g r oup s c omp a r e d  t o  c on tr o l s o I n c r e a s e d  
p roduc t i on and re l e a se o f  n ew e rythr ocy te s b y  eryth r o ­
poi e t i c ti s s u e s i s  in d i c a t e d  ( D avi d s ohn a n d  Nelson, 
1 969) . Tissue hy pox i a an d d e p r e s s ed oxyg en tr an s p o r t 
doe s e l i c i t s u ch a re s p on s e o 
Fe t a l  p a c k e d  c e l l  vo l u me s were s i gn i f i c an t l y  
dec re a s e d i n  tr e at men t g r ou p s  a l thou gh n o t s i gn i f i c an t ly 
between h i gh and l ow man g an e s e t r ea tmen t s . Hemogl ob in 
Va l u e s w e r e a l s o d e p r e s s e d i n  t re a tme n t  g r ou p s  ( h i g h ly 
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s i gn i f i can t l y ) o Lowe re d p ac k e d  c e l l  vo l ume s and h e m o -
g l obin l e ve l s  i n d i c a t e  e r y t h r o cy t i c di l u t i on by t i s s u e  
fluid i n f l ux o Th i s  a t te s t s  t o  the f a c t t h a t  t r e a t e d  
an i ma l s h ad a dec r e a s e d  abi l i ty t o  t r an sp o r t  o xy gen . 
Me an c o r p u s c u l a r vo l ume s an d me an c or p u s c u l a r  
hemo g l ob i n  l e ve l s  s h o w e d  h i g h l y s i gn i f i c an t  d e c re a s e s  
i n  t r e a tmen t an i ma l s wh i ch i s  c on s i s ten t wi th m i c r o c y t i c , 
hyp o c h romi c an e m i a s . Me an c o rpu s c u l a r h e mo g l ob i n  c o n c e n -
t r a t i on s we r e  i n c r e a s e d  ( h i gh l y  s i gn i f i c an t l y ) i n  t r e a t e d  
an i m a l s o  The s e  a r e  i n d i c a t i ve o f  b l o od vo lume r e d u c t i on 
wh i c h o c c u r s i n  s p h e r o c y t o s i s , an o c c a s i on a l  o c cu r r e n c e  
i n  n e wbo rn m a mma l s ( P l a t t , 196 9 ) .  
Re d b � oo d  c e l l e n u me r a t i on s  an d p l a s ma i ron 
l e ve l s  were n o t s i gn i f i c an t l y  d i f f e r en t in tre a tmen t 
group s . P l a s ma m an g ane se con centra t ions w e r e  a l s o  un -
c h an ge d . H ow e ve r , re d b l oo d  c e l l  man g an e s e  l e ve l s  w e re 
e l e va t e d  o ve r  two - fo l d  i n  t r e a t e d  a n i m a l s ,  � h i gh ly 
s i gn i fi c an t  s t a t i s t i c a l  d i f f e r e n c e . T h e  in te r f e r e n c e  0 £  
man g ane s e  i n  n o rm a l  h e mo g l ob i n  f o rm a ti on a c c oun t s  f o r  
t h e  ove r a l l d e c re a s e  o f  h e mo g l o b i n  valu e s . T h i s i s  i n  
agr e e men t w i th the f i n d in g s  o f  H a r tman e t  a l . ( 19 5 5 ) ,  
M a t r on e  et a l . (1959) an d Cunn i n g h a m  et a l . ( 1966) . - -
H i gh l y s i gn i f i c an t  d e c re a s e s  were f oun d i n  c i r -
cu l a t i n g  l e uk o c y t e  n umbe r s  i n  t r e a t me n t  g r ou p s . 
pe n i a  w a s a c o mmon l ab o r a to r y  f in d i n g  i n  c h r o
n i c 
L e u k o -
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man g ane s e  p o i s on i n g  ( C o t z i a s ,  1 9 5 8 ) . The c omp l e t e  l e u k o ­
cy t i c  a l t e r a t i on s  o f  t h i s l e ukopen i a  c ou l d  n o t  b e  d e t e r ­
m i n e d  w i th ou t  w h i t e  b l o o d  c e l l  d i f f e r e n t i al and b o n e  
marrow s tu d i e s . I n t e r e s t i n g ly , d i s s emin a te d  l u p u s 
e r y th ema t o su s , a d i s e a s e  c h a ra c t e r i z e d  by l eu k o p en i a , 
w a s  i mp r o ve d  b y  m an g an e s e i n j e c t i on ( C omen s , 1 9 5 6 ) . 
The w e t we i gh t s  o f  f e t a l  c arc a s s e s  w e r e  s i gn i f ­
i c an t l y  re d u c e d  i n  t r e a t e d  an i m a l s .  C o t z i a s  ( 1 9 5 8 )  
r e p o r t e d  d e c r e a s e d  b o dy w e i gh t  t o b e  s y mp t o m a t i c  o f 
exc e s s i ve man g an e se i n t ak e , p r e s umab l y  du e t o  i t s  g e n e r a l  
tox i c ity . 
Fe t a l  h e ar t w e i gh t s ,  c ompu t e d  a s  p e rc e n t  o f  
to t a l  b ody w e i gh t , w e re h i gh l y  s i gn i f i c an t l y d e c r e a s e d  
i n  t r e a t e d  ani m a l s .  T h e  h e ar t  h a s  b e en s h own t o  c o n t a i n  
very s ma l l  a moun t s  o f  man g an e s e , bo th n a tu r a l l y  a n d  
foll owi n g i n j e c t i on ( S c h r o e de r , Ba l a s s a  an d T i p ton , 
1 9 6 6 ) 0 Von O e t t in g en ( 1 9 3 5 ) r e p o r t e d  h i s to l o g i c a l 
s tudi e s  s h o w i n g c a r d i ac d e g en e r a t i on . I n  the ab s e n c e  
of d e f i n i t i ve h i s t o l o g i c a l  i n ve s t i g a t i on s , t h e  we i g h t  
ch an ge s were e x p l a i n e d by man g an e s e  i n te r f e re n c e  with 
p r o l i f e r a t i on of n o r m a l  t i s s u e . 
Lun g t i s s u e  h a s  b e e n  found to c on t a i n  very s m a l l 
amoun t s  o f  m an g ane s e , bo th n o rma l l y  an d f o l l o w i n g  l ar g e  
man g an e s e  i n j e c t i on s ( S c h r o e d e r , B a l a s s a  an d T i p ton , 
1 9 6 6 ; Un d e rw o o d ,  1 9 7 1 ) .  F e t a l  l u n g  we i gh t s  w e r
e  
3 1  
inc r e a s e d  ( h i g h l y  s i g n i f i c an t l y ) in t r e a t e d an ima l s .  
Due to the s ma l l  m an g an e s e c on ce n tr a t i on s  f o un d  i n  l un g s  
a f t e r  i n j e c t i on , i t  i s  do ub t fu l i f  t h i s i n c r e a s e  w a s  d u e  
t o  p ro l i fe r a t i on o f  m ac r o p h a g e s o M o r e  l ik e l y , i t  wa s 
due t o  a c o mb i n a t i o n  o f  f a t ty de gene r a t i on a s  f ound in 
o th er t i s s u e s  ( von De t t i n g e n , 1 9 3 5 ) and t o  f e t a l  hyp ox i c  
a l t e r a t i on s o 
3 2  
Fe t a l  l i ve r  w e i g h t s  w e r e in c r e a s e d  s i gn i f i c an t l y . 
Du e to h e p a t i c  exc r e t o ry fun c t i on s  i n  man g an e s e  tu rn o ve r , 
th e s e i n c r e a s e d  l i ve r  w e i g h t s  w e r e  prob ab l y  a man i fe s t a ­
t i on o f  e l e va t e d  w o rk l o ad ( C o t z i a s , 1 9 5 8 ; Un d e rw o o d , 
1 9 7 1 ) 0 H i s t o l o g i c a l l y , l i ve r  o f  man g an e s e  t r e a t e d  
an i ma l s h a s  b e en s hown t o  b e  in a s t a t e o f  f a t ty d e g en e r ­
a t i on ( von D e t t in gen , 1 9 3 5 ) 0 
K i dn e y  w e i g h t s  w e re s i gn i f i c an t l y  d e p r e s s e d . 
K i dn e y s  c on t ai n  l a r g e  c on c e n tr a t i on s  o f  man g an e s e , 
s econd on l y  to th e l i ve r an d p an c re a s  ( S c h � o e d e r , 
Bal a s s a  an d T i p ton , 1 9 6 6 ) . K i dney s o f  man g an e s e  t r e a t e d  
a n i m a l s we re n e p h r i t i c , c i r r h o t i c  an d de gen e r a t in g 
( von Oe t t in g en , 1 9 3 5 ) 0 The obvi ou s l y t o xic e f f e c t s  o f  
m an g an e s e  o n  a du l t  o r g an s  p r o b ab l y in t e r f e r e d  i n  the 
d e ve l op men t a l proce s s e s o c c u r i n g  i n  th e f e tu s . 
T h e r e f o r e , th e r e  are man g an e s e - i ron re l a t i on ­
s h i p s  a l te r i n g  hemo g r a m p ar ame t e r s , p l a s m a  man g an e s e  an d 
i r o n c on c en t r a t io n s a n d  t o t a l  b o dy an d cer tain org an 
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weigh t s . 
SUMMARY 
Man g an e s e , a tr a c e  e l emen t , h a s  b e en known t o  be 
e �s en t i a l  f o r  an ima l  nu t r i t ion s in c e  1 9 3 1 0 I t s  d e f i ­
c iency in p r e gn an t  an ima l s  c au s e s profound fetal devel ­
opmen t a l  ch an ge s ,  e s p e c i a l l y in o s s if ic a t i on p r o c e s s e s . 
E x c e s s  man g an e s e  in t e r f e r e s  w i th iron me tabo l i s m . The s e  
i n ve s t i g a t i on s  a t temp t e d  c l arifica tion o f  h igh ma t e rn a l  
man g an e s e e ff e c t s  o n  p l ac en t a l  iron tran s p o r t ,  f e t a l  
e rythropoie s i s , fe t a l  l euk ocy te form a t i on an d o r g an o ­
g en e s i s o 
Twen ty -one Du tch -b e l t e d  fema l e  r abb it s and 1 3 8 
f e tuses were u t i l i z e d  in the s e  s tu d ie s o An im a l s wer e  
r an do m l y  a s s i gn e d  t o  a c on tro l g roup ( Group I ) , a l ow 
l eve l man g an e s e  tr e a tme n t g roup ( Gro up I I ) or a h ig h  
l evel man g an e s e  tr e atmen t g roup · ( Group I I I ) . Group I 
rec e ived 1 0  ml O o 8 5% N aC l , Group I I  re c e ive d 2 o 5 mg man­
gan e s e  p e r  k i l ogram an d Group I I I  rec e ived 1 0  mg m an g an ­
e s e  p e r  k i l o g r am in t r ap e r i ton e a l ly o n  Day 2 2  t o  D ay 2 4  
o f  p re gn ancy . Bl o o d  s amp l e s  were ob t a i n e d  imme d i a t ely 
be fore t r e at me n t  and s ac r if ic in g o  R e d  bl ood c e l l s ( RBC )  
an d wh i te b l oo d  c e l l s  ( W BC ) were enumerated e l e c tr o n ­
ic al l y o Al so me a s ur e d  w e r e  p ac k e d  cel l vo l u me s  ( P CV ) , 
he mog l obin l e ve l s , ret i cul ocytes , whi t e  bl o o d  cell d i f­
fe ren t ial s ,  mean c o rp u s c u l a r hemo g l ob in ( MCH ) , me an 
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c orpu s c u l a r  vo lume ( MCV ) , me an corpu s cu l ar hemo g l ob i n  
c on c en t r a t i on ( MCHC ) , r e d  b l o o d  c e l l  and p l a s ma iron and 
re d b l oo d  c e l l  and p l a s ma man g an e s e  con c en t r a t i on s 0 
F e t a l  b l o o d  s amp l e  ana l y s i s inc l u d e d  R BC , WBC , 
P C V , nemo g l ob in l e ve l s , r e t i cu l ocyte s ,  MCH , MCv , ·  MCHC , 
r e d  b l ood c e l l an d p l a s m a  i ron and r e d  b l o od c e l l  and 
p l a sma man g an e s e  l e ve l s .  We t w e i gh t s  of f e t a l  l i ve r , 
h e ar t , l e f t l un g , r i gh t  k i dn ey and to t a l  body w e i gh t s  
w e r e  me a s u re d . 
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U t i l i z in g  an a l y s i s  of va r i anc e  no s i gn i fi c an t  
di f f e renc e s  w e r e  d emon s tr a t e d  i n  the doe d a t a . Howeve r ,  
fe t a l  d a t a  s howe d s i gn i f i c an t  a l t e r a t i on s  i n  t r e a t e d  
an imal s .  Re t i c u l oc y t e  numbe r s  we re incre a s e d  h i gh l y  
s i gn i fi c an t ly wh i l e  r e d  b l o o d  c e l l s  d i d n o t  di f f e r  b e ­
twe en g roup s . He mo g l ob iri l e ve l s  were de p r e s s e d  ind i ­
c a t i n g  t h a t  e ven t hough r e d  b l ood c e l l  numb e r s  w e r e  t h e  
s ame ,  oxy g en c a r ry in g c ap ab i l i ty w a s  l ow e re d . Hemo g l ob in 
we i gh t  p e r  c e l l  w a s  d e c r e a s e d  a s  e vi d enc e d  by l ow e r e d  
MCH va l u e s  a l though MCHC con c en t r a t i on s  in d i c a t e d  h e mo ­
g l o b in perc e n t  e l e va t i on , p rob ab l y  due t o  sph erocy to s i s .  
PCV va l u e s  were d e c r e a s e d  i n d i c a t i n g  t i s su e  f l u i d  move ­
men t in to th e c a rd i o va s cu l a r sy s tem a s  RBC va l u e s r e ­
mained t h e  s ame . Wh i te b l o od c e l l f o r ma t i on wa s  d e -
pre s s e d  h i gh l y  s i gn i f i c an t ly .  
No di f f e rence w a s  d e mon s tr a te d i n  r e d  b l o od c e l
l  
i ron , p l a sma i ron o r  p l a sma man g ane se l e vel s .  H owe ve r , 
red b l ood c e l l man gan e s e  concen tration s  we re doub l e d , a 
h i gh l y  s i gn i f i c an t  d i f fe renc e o 
F e t a l  body we i gh t  w a s  h i gh l y  s i gn i fi c an t l y  re ­
duc ed . Al s o  f e t a l  h e a r t  and kidney h ad l ow e re d  o r g an 
we i ght s w h i l e  l i ve r and l ung i n c re a s e d  h i gh l y  s igni fi ­
can tl y . 
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S tu d i e s  o f  a man g an e s e - i r on an t ag on i sm in t h e  
nu t r i t i on o f  r a bb i t s  an d baby p i g s .  J .  N u t r . 
6 7 : 3 0 9 . 
McHarg ue , J .  s .  1 9 2 3 . E f f e c t  o f  d i f f e r en t concen t r a �i on s  
o f  man g an e s e  s u l ph a t e  on th e grow th o� p l an t s _ 
in 
a c id an d n e u t r a l  s o i l s  and the n e c e s s i
ty o f  man g an ­
e s e  a s a p l an t  nu tr i e n t .  J .  Ag r . Re s . 2 4 : 7 8 1 . 
4 1  
McN ary , W .  F . , Jr . 1 9 6 0 . T h e  h i s tochemi c a l  d emon s t r a t i on 
o f  t r ac e  me t a l s in l e ukocy te s o J .  Hi s tochem 0 and 
Cytoc h e m o 8 : 1 2 4 0 
Me i r i , u .  and R .  R ah amimo f f . 1 9 7 2 . N eu r omu s cu l ar tr an s ­
mi s s i on : I nh i b i t i on b y man g an e se i on s . S c i enc e 
1 7 6 : 3 0 8 . 
Men a , I . , K o  Horiuch i , K .  Burke and G o  C o  C o t z i a s . 1 9 6 9 . 
C h r on i c  man g an e s e  p o i s on ing . N eu ro l o g y  1 9 : 1 0 0 0 . 
Men a , I . , J .  C ou r t , S �  Fuen z a l i d a , - P .  s .  P ap ava s i l i ou an d 
G o  C .  C o t z i a s . 1 9 7 0 . Mo d i f i c a t i on o f  ch ron i c  m an ­
g an e s e  po i s on i n g : Tre atme n t  wi th L -Dop a or 5 -0H 
try p t o p h an e . N o  E n g . J .  Med . 2 8 2 : 5 .  
Men a , I . , o .  M a r i n , S .  F u e n z a l i d a  and G .  c .  C o t z i a s . 
1 9 6 7 0 C h ron i c  man g an e s e poi s on in g . N eu ro l o gy 
1 7 : 1 2 8 . 
Mye r s ,  v .  C .  an d H .  H o  Be ard . 1 9 3 1 . S tu d i e s  i n  the 
nu tri t i on a l  a:i e.mi a o f  the r a t . I I  .. I n f l u en c e o f  
i ron p l u s  s u pp l e men t s  o f  o th e r  inor g an i c  e l emen t s  
upon b l oo d  r e gen e r a t i on . J .  B i o l . C h em . 9 4 : 8 9 .  
New l an d , H .  w .  and G .  K .  Davi s . 1 9 6 1 . P l ac en t a l  t r an s f e r  
o f  m an g an e s e  i n  s w i n e o J .  An i m . S c i . 2 0 : 1 5 .  
P ap ava s i l i ou , P .  s .  and G .  c .  Co t z i a s . 1 9 6 1 . N e u t r on 
ac t i va t i on an a l y s i s : T h e  d e t e rmin a t i on o f  m an g an ­
e se . J .  Bi o l . C h em . 2 3 6 : 2 3 6 5 . 
P ap ava s i l i ou , P .  s . , s . T .  Mi l l e r and G .  C .  Co t z i a s . 
1 9 6 6 . Ro l e  o f  l i ve r  in r e gu l a t i n g  d i s tr ibu t i on and 
e xc r e t i on o f  man g an e s e . Ame r . J .  P hy s io l . 2 1 1 ( 1 ) : 
P l a t t ,  
2 1 1 . 
w .  R .  1 9 6 9 . C o l o r  At l a s  and Textbook o f  Hema t o l ­
ogy . J .  B .  L i pp i n c o tt C o . , P hi l ade l ph i a . 
Po l i ack , s . ,  J .  N .  Ge o r g e , R .  c .  Reba , R .  M .  Kaufman an d 
w . H .  C r o sby . 1 9 6 5 . The ab s o rp t � on o f  n on - f e r r ou s · 
me t a l s  in i ron d e f i c i ency .  J .  C l in . I n ve s t . 
4 4 : 1 4 7 0 . 
Ruben s te in , A . H . , N .  w . Levin and G .  A .  E l l io t . 1 9 6 2 . 
Man g ane s e - induced hyp o g l y c e mi a . L anc e
t  2 : 1 3 4 8 �  
S ah ag i an , B .  M . , I .  H a rd i n g -B e r l ow an d H o · M .  P er ry , Jr . 
1 9 6 7 .  T r an s mu r a l  move men t o f  z i n c , m an g an e s e  
d . 
' c a  miu m  an d me r c u r y  b y  ra t sma l l  in te s t i n e o J .  
N u tr . 9 3 : 2 9 1 . 
4 2 
S a t o , M .  an d K .  Mu r at a . 1 9 3 2 . Man g an e s e  con ten t o f  m i l k . 
J .  D a i r y  S ci . 1 5 : 4 6 1 . 
S awhney , P . C .  an d N .  D .  Keh ar . 1 9 6 1 . I n ve s t i g a t i on s  on 
tra ce  e l emen t man g an e s e . I I I . Vari a t i on s  in t h e  
man g an e s e  c on ten t o f  b l o o d  and ti s su e s of c at t l e . 
Ann . B i oc h e m . Exp . Med o 2 1 : 1 2 5 . 
S c h a ib l e , P .  J .  an d s .  L .  Bandemer � 1 9 4 2 . Th e e f fec t of 
mine r a l  s u p p l e men t s  on the avai l ab i l i ty o f  man g an ­
e s e . P ou l . S c i . 2 1 : 8 .  
S c h ro e d e r , H .  A . , J .  J .  Ba l a s s a  an d I o  H .  T i p ton . 1 9 6 6 . 
E s s en t i a l  t r a c e  me t a l s i n  man : M an g an e se . J .  
Chron o D i s . 1 9 : 5 4 5 . 
S c ru t t on , M .  c . , M .  F .  U t l e r  and A .  S .  Mi l d van . 1 9 6 6 . 
Pyruv a t e  c arboxy l a s e . VI . The pre sence o f  t i g h t l y  
boun d man g ane s e . J .  Bi o l . C h e m . 2 4 1 : 3 4 8 0 . 
Shrade r ,  R. E .  an d G .  J .  E ver s on . 1 9 6 8 . P anc re a t i c  
p a tho l o gy i n  man g an e s e -defi c i e n t guin e a  p i g s . J . 
N u tr . 9 4 : 2 6 9 0 
Thibode au , G .  A .  1 9 6 7 . E f fe c t s  o f  o r a l l y  admin i s t e r e d  
s o d i u m  D- thyroxine upon p r e gn an cy p ro gre s s i on i n  
eu thyroid r abbi t s  and i t s  e f f e c t  upon the n e wb o rn . 
M .  s .  The s i s .  Sou th Dakota S t ate Un i v e r s i ty , . 
Brook i n g s , S ou th D ako t a . 
Th i e r s , R .  E .  and B .  L .  V a l l e e . 1 9 5 7 .  D i s t r i bu tion o f  
me t a l s i n  subce l l u l ar frac t i on s  of r a t  l i ve r . J . 
Bi o l . Che m . 2 2 6 : 9 1 1 . 
T i p ton ,  I .  H . , P .  L .  S tewa r t  an d P .  G .  M a r t i n . 1 9 6 6 � 
T r ac e  e l emen t s  in d i e t s  an d excre t a . He a l th 
P hy s i c s 1 2 : 1 6 8 3 . 
T i tu s ,  R .  w . , H .  w .  c ave and J .  S .  Hu ghe s . 1 9 2 8 . T h e  
m an g ane s e -copp e r - i r on comp l ex a s  a fac tor i n  h e mo ­
g l ob i n  bu i l d in g . J .  Bi o l . Chem . 8 0 : 5 6 5 . 
Unde rwoo d , E .  J .  1 9 7 1 . T r ac e  E l emen t s  in Human an d 
An ima l N u t ri t i on ( 3 r d  E d . ) .  Ac a
demi c P re s s , N ew 
York . 
4 3  
von Oe t t in g en , W o  F o  1 9 3 5 0 M an g an e s e : 
ph armac o l o gy and h e a l th h a z ard s . 
1 5 : 1 7 5 . 
I t s d i s t r i b u t i on , 
Phy s i o l . Rev . 
Wac h te l , L o  W o , C o  A .  E l ve hjem and E .  B .  Har t . 1 9 4 3 . 
S tu d i e s on the phy s i o l ogy o f  man g an e s e  in the r a t . 
Ame r . J o P h y s i o l . 1 4 0 : 7 2 .  
Wa de , D o  A .  1 9 7 2 . E f fe c t s o f  man g an e s e c h l or i d e  on g r a vi d 
g i l t s  an d newborn p i g s o P h . D .  The s i s . S ou th D ak o t a  
S ta te U n i ve r s i ty , Br ook in g s , S ou th D ak o t a . 
We inbe r g , E o  D .  1 9 6 4 0 Man g an e s e  r e qu i remen t f o r  s p o ru l a ­
t i on an d o th e r s e c on d a ry b i� s y n th e t i c  p ro c e s s e s  o f  
Bac i l l u s o App l o M i c r ob i o l o 1 2 : 4 3 6 . 
Wi l gu s , H .  s . , J r . an d A .  R o  P a tton o 1 9 3 9 . F ac t o r s  
a f fec tin g man g an e s e  u t i l i z a t i on in th e c h i c k en . 
J .  N u tr . i 8 : 3 5 .  
4 4  
AP P E N DI X  
An im a l  We i gh t  
g 
Gr ou p I ( C on t ro l ) 
1 2 0 5 0  
2 2 0 5 0  
3 2 2 7 0 
4 2 2 6 0  
5 1 9 6 5  
6 2 2 9 0  
7 2 1 0 0  
Me an 2 1 4 1 
Group I I  
1 2 1 3 0 
2 2 2 1 0  
3 2 3 2 0  
4 2 2 6 0  
5 2 3 5 0 
6 2 3 3 0 
7 1 8 8 0  
Me an 2 2 1 1 
Group I I I  
l 2 4 1 0  
2 2 6 0 0  
3 2 4 9 0  
4 2 6 6 0 
5 2 3 0 0 
6 2 5 4 0  
7 2 1 5 0  
Me an 2 4 5 0  
RAW DA'fA TABLE I 
P R E -TREATMEN T SAMPLE S 
R BC 1 
9 . 1 7  
5 . 4 2 
6 . 2 0 
5 . 8 9  
6 . 4 2 
4 . 6 6  
5 . 3 9 
6 . 1 6  
6 . 4 4 
5 . 4 5  
5 . 1 5  
5 . 7 1 
5 . 7 3 
6 . 1 1 
5 . 6 5  
5 . 7 5 
5 . 5 5  
5 . 3 2  
6 . 1 6 
5 . 0 8  
5 . 8 5  
5 . 8 0 
5 . 8 8  
5 . 6 6  
WBC 2 
4 . 8 4 
5 . 4 9  
6 . 1 6  
8 . 5 5  
6 . 7 6 
5 . 5 3  
3 . 0 0  
5 . 7 6 
5 . 4 0 
4 . 4 2 
4 . 4 3 
5 . 4 1  
3 . 6 4 
5 . 5 8  
7 . 4 0  
5 . 1 8  
5 . 3 1 
5 . 6 1  
6 . 4 0 
3 . 7 6 
5 . 5 7  
5 . 7 9 
6 . 2 2 
5 . 5 2 
6 3 
P C V 3 
% 
3 2 . 0  
.. 3 5  0 5 
3 8 . 0  
3 8 . 0  
4 2 . 5  
3 3 . 5  
2 7 . 0 
3 5 . 2  
3 8 . 0  
3 7 . 0 
3 3 . 0  
3 6 � 5  
3 7 . 0 
3 7 . 5  
3 5 . 5  
3 6 . 4  
3 6 . 0  
3 4 . 5  
3 9 . 5  
3 2 . 5  
3 6 � 0  
3 8 . 5  
3 7 . 0  
3 6 . 3 
l · Red B l o o d  C e l l s  x 1 0  /mm • 
2Wh i te B l o o d  C e l l s  x 
3 P ac ke d  C e l l  Vo l ume. 
4 H e mo g l o b i n . 
4 3 
1 0  /mm • 
5 Re t i cu l o c y te s p e r  1 0 0 0  e ry th r o c y t e s .  
4 5  
Hb
4 
R e t i cu l g-
g% cy te s 
1 0 . 9  1 . 7  
1 1 . 5  2 . 3  
1 1 . 7  2 . 3  
1 1 . 4  2 . 1 
1 1 . 0  1 . 6 
1 0 . 3 4 . 0 
9 . 9 L . 4  
1 1 . 0  2 . 2 
1 2 . 4 1 . 5  
1 2 . 3 3 .. 0 . 
l l e 5  2 . 7  
1 2 . 2  3 . 0 
1 2 . 2  1 . 6 
1 2 . 8  2 . 7 
1 1 . 5  1 . 6 
1 2 . 1 2 . 3 
1 1 . 7  2 . 5 
1 1 . 2  2 . 4 
1 2 . 9  1 . 8 
1 0 . 6  4 . 1  
1 2 . 4  2 . 9 
1 3 . 3  1 Ci 6 
1 2 . 0  2 . 6 























RAW DATA TABLE I I  
P RE -T REATMENT SAMPLE S 
P l a s ma RBC P l a s ma 
F'e Mn Mn 




( C on t r o l ) 
3 2 . 8 1 0 . 4 8  8 . 1 1 4 . 4 0  1 1  .. 8 9  
3 2 . 6 5 0 . 3 1 6 . 0 6  7 . 3 2 2 1 . 2 4 
3 7 . 5 2 0 . 1 9 4 . 4 0 4 . 1 7  1 8 . 8 7  
3 5 . 9 6 0 . 1 8 5 . 5 1 3 . 9 3 1 9 . 3 4 
3 6 . 7 3 0 . 3 1 6 . 1 4 5 . 0 3  1 7 . 1 3 
2 8 . 3 3 0 . 6 1 4 . 0 9  6 . 1 4 2 2 . 0 8 
2 6 . 6 4 0 . 2 3  3 . 8 0  5 . 4 5  1 8 . 3 7 
3 2 . 9 4 0 . 3 3 5 . 4 4 5 . 2 0  1 8 . 4 1 
3 6 . 9 0 0 . 6 4  6 e 4 5 7 e 48 1 9 . 2 7  
3 2 . 0 3  0 . 8 0  o . o o  7 . 2 4 2 2 . 5 7  
2 8 . 7 4 0 . 1 9 o . o o  6 . 0 3  2 2 . 3 3  
2 9 . 8 3 0 . 1 5  3 . 3 8 7 . 1 9 2 1 . 3 7  
5 5 . 6 1 0 . 3 6 5 . 9 9  1 1 . 1 0 2 1 . 2 7 
3 4 . 5 8 0 . 7 8 3 . 2 2  6 . 0 3  2 0 . 9 3 
2 9 . 6 6  0 . 4 0 2 . 8 9  5 . 4 5  2 0 . 3 5 




3 4 . 8 9 
6 5 . 5 6 
6 1 . 2 9 
6 4 . 4 6 
6 6 . 2 0 
7 1 . 8 1 
5 0 . 0 9 
5 9 . 1 8 
5 9 . 0 5  
6 7 . 8 9 
6 4 . 0 8 
6 3 . 9 2  
6 4 . 5 2 
6 1 . 3 2 
6 2 . 8 3  
6 3 . 3 7 
Group I I I  
1 3 4 . 7 2 0 . 0 9 7 . 7 5 4 . 0 0 2 1 . 0 6  · 6 4 . 8 1 
2 2 5 . 1 2  0 . 2 3 1 0 . 3 5 o . o o 2 1 . 0 3  6 4 . 7 9  
3 3 8 . 1 8 0 . 0 9 8 . 9 2  4 . 0 4  2 0 . 9 4 6 4 . 1 2 
4 2 0 . 8 4 6 3 . 9 1 
5 3 1 . 5 6 0 . 1 5  o . o o  5 . 7 7  2 1 . 1 8 6 1 . 48 
6 2 2 . 9 1  6 6 . 3 2 
7 3 1 . 7 7 0 . 2 2  4 . 0 4  6 c 0 3  2 0 . 3 9 6 2 . 8 7  
Me a n  3 2 . 2 7  0 . 1 5 6 . 2 1  3 . 9 6 2 1 . 1 9 6 4 . 0 4 
l 
M e an Corpu s c u l a r  He mog l obin . 
2 
Me an C orpu s c u l ar Vo l ume . 
3 
Me an Corpu s cu l ar Hemo g l obin Conc e n t r a t i
on • 




3 4 . 0 6 
3 2 . 3 9 
3 0 . 7 9 
3 0 . 0 0 
2 5 . 8 8 
3 0 . 7 5 
3 6 . 6 7 
3 1 . 5 0 
3 2 � 6 3 
3 3 . 2 4 
3 4 . 8 5  
3 3 . 4 2 
3 2 . 9 7  
3 4 . 1 3 
3 2 . 3 9 
3 3 . 3 7 
3 2 . 5 0 
3 2 . 4 6 
3 2 . 6 6 
3 2 . 6 1 
3 4 . 4 4 
3 4 . 5 4 
3 2 . 4 3 
3 3 . 0 9 
RAW DATA TABLE I I I  
F I NAL SAMPLES 
Ani m a l  We i gh t  R BC 1 W BC 2 
g 
Group I ( C on tr o l ) 
1 2 0 5 0 9 o l l 3 . 9 1  
2 2 0 4 1  4 . 8 3  4 . 2 1 
3 2 2 8 0  5 . 0 3  3 o 7 7 
4 2 2 9 0  5 . 3 8 4 o 4 4 
5 2 1 8 0  5 . 5 8  8 . 1 4  
6 2 3 7 0 4 . 1 7 4 . 0 3  
7 1 9 5 0 4 . 3 1 2 . 7 6 
Me an 2 1 6 6  5 . 4 8  4 . 4 6 
Group II 
1 2 2 4 0  9 . 4 0 3 . 9 5  
2 2 1 2 0  3 . 5 9 7 . 6 2  
3 2 3 0 0  4 .  3 '/ 3 . 6 3  
4 2 3 0 0  4 . 8 6 5 . 4 0 
5 2 4 1 0  4 . 8 1  3 . 6 3  
6 2 3 9 0  5 . 2 1 5 . 2 5  
7 1 9 5 0  5 . 3 8  1 0 . 1 7  
Me an 2 2 4 4  5 . 3 7  5 . 6 6  
Group I I I  
1 2 4 4 0  4 . 8 1  4 . 5 4 
2 2 5 6 0 4 . 9 0  4 . 1 1 
3 2 3 6 0  4 . 6 3 8 . 6 6 
4 2 4 4 0  s . 1 0 9 . 3 6 
5 2 2 0 0  4 . 9 5  5 . 7 0 
6 2 6 5 0  5 . 0 3 6 . 7 0 
7 2 1 0 0  4 . 9 7  6 . 7 0  
· Me an 2 3 9 3  4 . 9 1 6 . 5 3 
1 Re d B l ood C e lls x 
6 3 1 0  / mm • 
2.Wh i te B l o o d  Ce l l s  x 
3 P ack e d  Ce l l  Vol ume • 
4He mo g l ob in • 
1 0 4 /mm 3• 
P C V 3 
% 
3 1 . 0  
3 5 . 0  
.. 3 2  . o  
3 5 . 5  
3 4 . 0  
3 0 . 0  
2 7 . 5  
3 2 . 1  
3 3 . 5  
2 6 . 0  
2 9 . 0  
3 2 . 0  
2 8 . 5  
3 3 . 0  
3 7 . 0  
3 1 . 3  
3 2 . 0  
3 3 . 0  
3 0 . 5  
2 9 . 5  
31 . 0  
3 3 . 5  
3 3 . 0  
3 1 . 8  
5 Re ticul ocy te s p e r 1 0 0 0  e r y th r oc y t e s . 
4 7  
Hb4 Re t i c u l g -g% c y t e s  
9 . 8 l o l  
1 0 . 4  2 . 2 
lO o O  2 . 2 . 
1 2 . 3  2 . 1 
1 1 . 6  4 . 0  
9 . 8 2 . 5 
8 . 8 1 . 5 
1 0 . 4  2 . 2 
1 1 . 6  2 . 8 
8 . 8 3 . 6  ' 
SJ 0 6 4 . 0  
1 0 . 0  5 . 3  
9 . 2 2 . 5 
1 0 . 4  1 . 5 
1 1 . 4  1 . 6 
1 0 . l  3 . 0 
1 0 . 1  3 . 0 
l � . o 3 . 5 
1 0 . 1  1 . 7  
9 . 3 3 . 6  
1 0 . 9  1 . 3  
1 1 . 3  2 " 5  
1 0 . 1  2 . 6 










M e an 










F e  
mg% 
RAW DATA TABLE I V  
F INAL SAMPLE S 
P l a s ma R BC P l asma 
Fe Mn Mn 
mg% u g% ug% 
( C ont ro l ) 
2 9 . 2 9 0 . 4 2  5 . 5 9 4 . 7 2 
3 0 . 5 5 0 . 2 5 4 . 8 1 5 . 6 4  
2 9 . 6 5 0 . 2 5 5 . 9 0  6 . 4 5  
2 6 . 2 3 0 . 1 6  6 . 3 7 3 . 3 0  
2 7 . 2 3 0 . 8 5 o . oo 6 . 1 1 
2 7 . 3 6 0 . 1 8 7 . 9 3  3 . 3 6 
1 9 . 6 6 0 . 8 3  3 . 7 1 5 . 2 8 
2 7 . 1 3 0 . 4 2  4 . 9 0 4 . 9 8 
3 4 . 5 1  0 ._ 2 9  7 � 8 7  4 . 0 9  
2 3 . 5 8 0 . 2 4 1 0 . 5 6 o . oo 
2 5 . 5 5 0 . 2 3 3 . 8 0  7 . 9 3 
3 0 . 4 2 0 . 3 0 4 . 0 4  7 . 3 5 
2 7 . 6 5 0 . 6 9  3 . 1 4  8 . 0 1  
3 3 . 5 4 0 . 2 6 4 . 0 4 6 . 6 9 
2 9 . 2 0 0 . 3 3 5 . 5 7  5 . 6 7  
Group I I I  
1 2 9 . 5 2  0 . 1 5  8 . 7 1 o . oo 
2 2 9 . 0 6  0 . 1 8 9 . 4 3 4 . 9 2  
3 2 0 . 5 9 0 . 6 5  3 . 4 7  5 . 1 2 
4 1 7 . 7 1 0 . 5 7 3 . 7 1 6 . 6 1  
5 2 5 . 2 1 0 . 2 2  o . oo 5 . 9 5 
6 2 5 . 2 1 0 . 3 9 3 . 8 8  9 . 0 9  
7 2 2 . 4 4 0 . 1 9 3 . 2 2 6 . 8 5 
Mean 2 4 . 2 4 0 . 3 3  4 . 6 3 5 . 5 0 
l 
Me an C orpu s cu l ar He mo g l obin • 
2 
Me an C o r pu s cu l ar Vo l ume . 
MCH 1 MCV2 
3 uug u 
1 0 . 7 6 3 4 . 0 3  
2 1 . 5 3 7 2 . 4 6 
1 9 . 8 8 6 3 . 6 2  
2 2 . 8 6 6 5 . 9 8 
2 0 . 7 7  6 0 . 8 8 
2 3 . 4 7 7 1 . 8 6  
2 0 . 3 9 6 3 . 7 3 
1 9 . 9 5 6 1 . 7 9 
1 2 . 3 3  3 5 . 6 2 
2 4 . 5 1 7 2 . 4 2 
2 1 . 9 4  6 6 . 2 8 
2 0 ., 5 5  6 5 . 7 7 
1 9 . 1 3 5 9 . 2 5 
1 9 . 9 4 6 3 . 2 8 
2 1 . 1 7  6 8 . 7 1 
1 9 . 9 3  6 1 . 6 1 
2 1 . 00 ' 6 6 . 5 3  
2 2 . 4 5 6 7 . 3 5  
2 1 . 7 9 6 5 . 8 0  
1 8 . 2 3  5 7 . 8 4 
2 2 . 0 2  6 2 . 6 3 
2 2 . 4 4 6 6 . 5 3 
2 0 . 3 2 6 6 . 4 0 
2 1 . 1 7  6 4 . 7 2  
3 
Mean C orpu s cu l ar Hemo g l ob i n  C oncen t
r a t i on . 
4 8  
MCHC 3 
% 
3 1 . 6 1 
2 9 . 7 1 
3 1 . 2 5 
3 4 . 6 5 
3 4 . 1 2  
3 2 . 6 7 
3 2 . 0 0  
3 2 . 2 8 
3 4  .. 6 ]  
3 3 . 8 5 
3 3 . 1 0 
3 1 . 2 5 
3 2 . 2 8 
3 1 . 1 5  
3 0 . 8 1 
3 2 . 4 3 
3 1 . 5 6 
3 3 . 3 3  
3 3 . 1 1  
3 1 . 5 2 
3 5 . 1 6 
3 3 . 7 3 
3 0 . 6 1 
3 2 . 7 1 





RAW DATA TABLE V 




Reticu l�- MCH 6 
cy te s uug 
No hemo g r am p ar ame te r s  avai l ab l e . 
Doe 2 
1 2 . 1 0  1 . 7 0 3 7 . 0  9 . 9 5 . 4 4 7 . 1 4 
2 3 . 7 3 7 . 8 4  4 4 . 5  1 1 . 8  7 . 2 3 1 . 5 9 
3 3 . 1 7  1 . 9 6  3 9 . 0  1 0 . 0  5 . 6 3 1 . 5 0 
4 3 . 7 2 3 . 2 7  4 4 . 5  1 1 . 7  7 . 3  3 1 . 4 5 
5 3 . 5 4 4 . 6 4  4 3 . 5  1 2 . 0  4 . 3  3 3 . 9 0 
6 3 . 5 9 3 . 9 5  44 . 0  1 1 . 7  7 . 6 3 2 . 5 4 
7 3 . 0 6  1 . 9 9  3 5 . 0  9 . 2 7 . 8 3 0 . 0 6 
Doe 3 
1 3 . 2 4  2 . 48 3 9 . 5  1 0 . 8  - - 3 3 . 2 8 
2 3 . 6 1  4 . 6 9 4 4 . 0  1 1 . 8  6 . 0 3 2 . 6 4 
3 4 . 0 9 4 . 7 6 48 . 0  1 2 . 7  5 . 5  3 1 . 0 5  
4 3 . 9 4  7 . 9 6  4 5 . 0  1 1 . 5  4 . 5  2 9 . 1 9 
5 3 . 1 0 5 . 6 4  3 6 . 5  9 . 2  7 . 0 2 9 . 6 8 
6 3 . 4 0 5 . 6 1  4 4 . 0  1 2 . 1  1 0 . 0  3 5 . 5 9 
Do e 4 
1 3 . 4 5  3 . 49 44 . 0  1 1 . 4  7 . 8 3 2 . 9 9 
2 3 . 5 4  4 . 1 2 4 4 . 5  1 1 . 1  8 . 5  3 1 . 3 5 





u 3 % 
1 7 6 . 1 9 2 6 . 76 
1 1 9 . 1 4 2 6 . 5 2 
1 2 2 . 8 3  2 5 . 6 4 
1 1 9 . 6 2 2 6 . 2 9 
1 2 2 . 88 2 7 . 5 9 
1 2 2 . 3 9 2 6 . 5 9 
1 1 4 . 3 8 2 6 . 2 8 
1 2 1 . 7 2 2 7 . 3 4 
1 2 1 . 7 1 2 6 . 8 2 
1 1 7 . 3 6 2 6 . 4 6 
1 1 4 . 2 1  2 5 . 5 5  
1 1 7 . 7 4 2 5 . 2 0 
1 2 9 . 41 2 7 . 5 0 
1 2 7 . 3 5 2 5 . 9 1 
l. 2 5 . 7 1 2 4 . 9 4  
1 2 4 . 8 1  2 6 . 9 0  
� 
\0 
RAW DATA TABLE V ( CONTINUE D ) 




PCV 3 Hb4 Reticu l e- MCH6 MCV 7 MCHC 8 
% g% cy te s S  uug u 3  % 
4 3 o 3 8 8 0 4 1 4 6 . 0  1 1 . 9  6 0 2 3 5 . 1 5 1 3 5 0 8 9 2 5 . 8 7 
5 4 . 3 1  7 . 2 5  5 2 . 0  1 2 . 0  5 . 1 2 7 . 8 4  1 2 0 . 6 5 2 3 . 0 8 
6 3 . 5 2  7 . 2 3  4 6 . 5  1 3 . 7  7 . 8 3 8 . 9 2  1 3 2 . 1 0 2 9 . 4 6 
7 3 . 2 2 1 4 . 7 9 3 9 . 0  1 1 . 0  4 . 5  3 4 . 1 6 1 2 1 . 1 2 2 8 . 2 0  
8 3 . 8 1  1 4 . 3 8 4 6 . 0  1 1 . 7  7 . 0 3 0 . 7 1 1 2 0 . 7 3 2 5 . 4 3 
Doe 5 
1 3 . 2 2  7 . 8 2  4 7 . 5  1 3 . 1  6 . 1  40 . 6 8 1 4 7 . 5 1 2 7 . 5 8 
2 3 . 1 5  9 . 1 2 4 4 . 0  1 1 . 9  8 . 2 3 7 . 7 8 1 3 9 . 6 8 2 7 . 0 4 
3 3 . 0 5 6 . 2 7  4 3 . 0  1 1 . 9 2 1 . 0  3 9 . 0 2 1 4 0 . 9 8 2 7 . 6 7 
4 3 . 2 3  1 . 7 4 4 3 . 0 1 1 . 5  4 . 0  3 5 . 5 5 1 3 2 . 9 2  2 6 . 7 4 
5 3 . 0 1  1 . 3 9 4 0 . 5  1 0 . 8  6 . 8 3 5 . 8 2  ,1 3 4 . 3 3 2 6 . 6 7  
6 3 . 2 6  1 . 5 9  4 2 . 0  1 1 . 4  7 . 0 3 4 . 9 7  1 2 8 . 8 3  2 7 . 1 4 
Doe 6 
1 4 . 2 9 2 . 0 5  5 3 . 0 1 4 . 0  6 . 6 3 2 . 6 0  1 2 3 . 40 2 6 . 4 1 
· 2 4 . 2 1 2 . 4 2  5 2 . 5  1 4 . 4  3 . 1 3 4 . 1 6 1 2 4 . 5 5 2 7 . 4 3 
3 3 . 9 1  1 . 5 8 5 0 . 0  1 3 . 5  6 . 5  3 4 . 5 3 1 2 7 . 8 8 2 7 0 0 0  
4 3 . 8 4  1 . 6 9  5 2 . 0  1 3 . 9  4 . 5  3 6 . 2 0 1 3 5 . 4 2 2 6 . 7 3 
5 3 . 7 6  1 . 9 0  5 1 . 0  1 3 . 5  3 . 5 3 5 . 9 0 1 3 5 . 6 4 2 6 . 4 7  
6 3 . 9 1  1 . 3 9 4 7 . 5  1 2 . 9  3 . 5  3 2 . 9 5 1 2 1 . 3 3 2 7 . 1 6 
7 3 . 9 2  2 . 2 6  4 9 . 0  1 2 . 9  5 . 7 3 2 . 9 1  1 2 5 . 0 0 2 6 . 3 3 
8 3 . 8 4  1 . 6 9  5 1 . 0  1 3 . 4  4 . 4 3 4 . 8 9 1 3 2 0 8 1 2 6 . 2 7  
9 4 . 1 5 2 . 4 1  5 1 . 5  1 3 . 2  6 . 0  3 1 . 8 1  1 2 4 . 1 0 2 5 . 6 3 
U1 
0 
RAW DATA TABLE V ( CONTINUE D ) 
F e tu s  RBC
1 
WBC
2 PCV 3 Hb4 Re t i cu l o - MCH 6 
% 
Doe 7 
1 3 . 7 9 2 . 3 8  4 7 . 0  
2 3 . 0 0  1 . 7 5 3 9 . 5  
3 3 . 2 8  1 . 3 6  4 0 . 0  
4 3 . 1 6  1 . 8 8  3 8 . 5  
5 3 . 2 a 1 . 7 9 4 3 . 0  
6 4 . 2 5 2 . 7 5 48 . 5  
7 3 . 9 2  1 . 8 0  48 . 0  
Me an 
3 . 5 4  4 . 2 2  44 . 8  
1 6 3 Red B l ood C e l l s  x 1 0  /mm • 
2






P acked Ce l l  Vo l u me . 
4
Hemo g l obin . 
g% cyte s 5 
1 1 . 9  1 0 . 7  
1 0 . 3  9 . 5 
1 0 . 4  8 . 9 
1 0 . 0  9 . 9 
1 1 . 1  8 . 0 
1 1 . 7 8 . 1  
1 2 . 1  6 . 1  
1 1 . 8 2  6 . 9 
5
Re ticu l ocyte s p e r  1 0 0 0  e rythrocy t e s . 
6
Me an Corpu scu l ar Hemo g l obin . 
7 
Me an Corpuscu l ar Vo l ume . 
8
Me an C o rpu s cu l ar Hemog l obin Concen tration . 
uug 
3 1 . 3 6 
3 4 . 2 8 
3 1 . 6 6 
3 1 . 5 9 
3 3 . 8 4 
2 7 . 5 0 
3 0 . 8 7  
3 3 . 6 0 
MCV7 MCHC 8 
u 3 % 
1 2 3 . 8 5  2 5 . 3 2 
1 3 1 . 4 5  2 6 . 0 7  
1 2 1 . 7 6 2 6 . 0 0 
1 2 1 . 6 4 2 5 . 9 7  
1 3 1 . 1 0 2 5 . 8 1 
1 1 3 . 9 8 2 4 . 1 2 
1 2 2 . 4 5 2 5 . 2 1 
1 2 7 . 1 7  2 6 . 3 9 
U1 • 
r-i 
RAW DATA TABLE VI 
GROUP I ( CONT ROL ) FETUS SAMPLE S 
F e tu s  T BW
1 
H e a r t  
2 L i ve r  2 Kidney 2 Lung 2 RBC F e  P l a sma Fe RBC Mn P l a sma Mn 
g mg% mg% ug% ug% 
Doe 1 
1 4 1 . 1  0 . 8 0  5 . 6 2  0 . 5 1  0 . 6 3  3 3 . 3 3 0 . 5 6 1  1 5 . 5 2 1 1 . 5 7  
2 3 0 . 2 0 . 6 0  6 . 2 4 0 . 5 6  0 . 7 3 
3 3 5 . 3  0 . 6 3  - - 0 . 5 8 0 . 7 2 
4 3 5 . 9  0 . 8 2  - - 0 . 6 0  0 . 5 9 
5 3 7 . 9 1 . 0 1  - - 0 . 5 4  0 . 7 4 
6 4 1 . 7  0 . 6 2  - - 0 . 5 0 0 . 6 1  
Do e 2 
1 4 1 . 7 0 . 5 8 5 . 9 1  0 ... 5 7  0 . 7 1 3 2 . 7 2 0 . 7 4 8  8 . 6 7  6 . 5 5 
2 3 7 . 4 0 . 6 3  5 . 6 4  0 . 5 4 0 . 8 4 
3 3 6 . 3  0 . 7 2 5 . 3 7  0 . 5 3  0 . 8 1  
4 3 5 . 7  0 . 7 8 5 . 7 7 0 . 6 4 0 . 8 2  
5 3 6 . l  0 . 7 6 5 . 6 8  0 . 5 9 0 . 8 7 
6 3 6 . 4  0 . 7 4 5 . 6 3  0 . 6 1  0 . 8 5  
7 4 3 . 9  0 . 7 4 6 . 2 7 0 . 6 5  0 . 8 4  
Doe 3 
1 40 . 0 o . 5 9  5 . 1 7  0 . 5 7 o . s 6  3 9 0 7 5 0 . 5 9 8  1 2 . 0 4 7 . 7 5 
2 4 6 . 3 0 . 7 1 6 . 0 3  0 . 6 1 0 . 7 2 
3 4 2 . 3  0 . 7 1  5 . 2 1 0 . 6 7 0 . 7 1  
4 3 4 . 8  0 . 5 3  5 . 2 3 0 . 5 3 o . s s  
5 3 6 . 2  0 . 6 8 5 . 0 8  0 . 5 9 0 . 6 0  
6 40 . 2  0 . 6 1  5 . 5 2  0 . 5 8 0 . 48 
(JI 
I\) 
RAW DATA TABLE VI ( CONTINUE D ) 
F e tu s  T BW1 Heart 2 Li ve r  2 K idney 2 Lun g  2 R BC Fe P l a sma Fe R B C  Mn P l a sma Mn 
g mg% mg% u g% u g% 
Doe 4 
1 4 2 . 2  0 . 6 3  5 . 5 1  0 . 6 1  0 . 7 5 3 2 . 7 2 0 . 8 1 2  1 0 . 1 9 5 . 5 5  
2 4 4 . 7  0 . 7 8 5 . 9 9  0 . 5 5  0 . 6 8 
3 3 3 . 6  0 . 6 7 5 . 6 3  0 . 5 1 0 . 6 7  
4 3 5 . 1  0 . 6 2  5 . 0 5  0 . 5 9 0 . 7 5 
5 4 2 . 5  0 . 6 6  5 . 8 5  0 . 5 1  0 . 5 7  
6 4 4 . 7  0 . 5 6 6 . 0 7  0 . 4 8  0 . 6 9 
7 4 6 . 9  0 . 6 5  5 . 7 0 0 . 4 9  0 . 6 2  
8 4 2 . 3  0 . 6 9 5 . 9 4  o . s s  0 . 7 0 
Doe 5 
l 3 7 . 3  0 . 6 7  6 . 3 4 0 . 4 8 0 . 6 5  3 1 . 7 9 0 . 8
1
9 8  9 . 5 9 6 . 1 4 
2 3 0 . 0  0 . 7 5 5 . 5 8 0 . 48 0 . 7 2 
3 3 0 . 5  0 . 7 4 5 . 7 8 0 . 5 2  0 . 7 5 
4 3 5 . 1  0 . 5 9 5 . 6 7 0 . 4 7 0 . 7 2 
5 3 7 . 6  0 . 6 0  6 . 3 1 0 . 4 4  0 . 6 8 
6 3 8 . 0  0 . 6 2  4 . 6 3 0 . 46 0 . 6 3  
Doe 6 
1 3 8 . 2 0 . 5 8 5 . 6 8 0 . 6 0 0 . 5 4 3 1 . 4 6 0 . 48 3  1 3 . 3 6 5 . 4 3  
2 4 0 . 7  0 . 6 9  5 . 6 5  0 . 6 8 0 . 7 5 
3 3 5 . 9 0 . 5 7  5 . 1 6 . 0 . 49 0 . 7 4 
4 3 2 . 6  0 . 7 5 5 . 1 7  0 . 4 9 0 . 9 1  
5 3 4 . 9  0 .. 6 5  5 . 4 5  0 . 5 0  0 . 6 3  
6 3 4 . 0  0 . 4 8 5 . 0-3 0 .. 5 1  O . E S  
U1 
w 
RAW DATA TABLE VI ( CONTINUE D ) 
F e tu s  T BW1 H e ar t  2 L i ve r  2 Kidney 2 Lung 2 RBC Fe P l a sma F e  
g mg% mg% 
7 3 2 . 5  0 . 6 5  5 . 6 7  0 . 5 3  O o 7 0 
8 3 9 . 5  0 . 7 2 6 . 0 5  0 . 4 9 0 . 6 8  
9 3 8 . 1 0 . 8 0  6 . 3 1 0 . 5 9 0 . 5 3  
Doe 7 
1 2 5 . 2  0 . 5 5  5 . 8 9  0 . 4 6  1 . 2 2  2 9 . 6 7 0 . 5 4 6  
2 2 2 . 7  0 . 5 1  5 . 5 0 O o 4 4 1 . 1 5  
3 2 3 . 0  0 . 6 1  5 . 7 5 0 . 5 6 1 . 1 2 
4 2 3 . 5  0 . 7 9 6 . 3 1 0 . 5 1 0 . 9 4  
5 2 5 . 1  0 . 6 2  6 . 0 3  0 . 4 9  0 . 88 
6 2 6 . 3  0 . 7 4 6 . 5 8 0 . 4 7  0 . 8 3 
7 2 4 . 8  0 . 6 0  6 . 0 8  0 . 5 0 0 . 9 7  
Me an 
3 6 . 0  0 . 6 6  5 . 7 0 0 . 5 3 0 . 7 3 3 3 . 0 6 0 . 6 6 3  
1
T o t a l  Body We i gh t .  
2
wei gh t  as percentage o f  t o t a l  body we i gh t .  
RBC Mn 
u g% 
2 1 . 1 5  
1 2 . 9 3  
P l a sma Mn 
u g% 
1 2 . 5 5 
7 . 9 3 
Ul 
� 
Fe tu s  RBC 1 W BC
2 
Doe 1 
1 6 . 7 8 1 . 2 9 
2 6 . 2 2  1 . 7 5 
Doe 2 
1 3 . 6 8  2 . 8 4  
2 3 . 9 5  2 . 1 9  
Doe 3 
1 3 . 6 4  1 . 7 6 
2 3 . 0 7  1 . 7 9 
3 3 . 6 4 1 . 9 0  
4 3 . 5 8 2 . 5 1 
Doe 4 
· 1 3 . 7 4 2 . 8 4  
2 3 . 8 9  1 . 8 5  
3 3 . 6 0 2 . 8 5  
4 3 . 8 9  4 . 3 0 
5 4 . 6 4  1 . 7 5 
6 3 . 9 5  2 . 5 7  
7 4 . 0 7  2 . 8 3 
RAW DATA TABLE VI I 





Re ticu l e - MCH6 
% g% cyte s 5 uug 
4 8 . 5  1 3 . 7  8 . 9 2 0 . 2 1 
4 7 . 0 1 3 . 9  1 4 . 2  2 2 . 3 5 
4 7 . 5  1 3 . 2  6 . 7  3 5 . 8 7  
49 . 5  1 3 . 9  5 . 6 3 5 . 1 4 
4 2 . 5 1 2 . 0  1 2 . 0  3 2 . 9 7  
4 7 . 0 1 1 . 5  7 . 9 3 7 . 4 6 
4 0 . 0  1 2 . 3 9 . 1 3 3 . 7 9 
4 3 . 0  1 2 . 0  9 . 5 3 3 . 5 2 
. 4 4 . 0  1 1 . 2  8 . 9 2 9 . 9 1  
4 6 . 0  1 1 . 5  8 . 8 2 9 . 5 2 
4 2 . 5  1 0 . 5  8 . 8 2 9 . 1 7  
5 1 . 5  1 2 . 9  8 . 7  3 3 . 1 6 
5 6 . 5  1 3 . 7  6 . 7  2 9 . 4 9 
4 6 . 0  1 1 . 6  1 2 . 5  2 9 . 3 3 




u 3 % 
7 1 . 5 3  2 8 . 2 5  
7 5 . 5 6 2 9 . 5 7 
1 2 9 . 0 8 2 7 . 7 9 
1 2 5 . 1 6 2 8 . 0 8 
1 1 6 . 7 6 2 8 . 2 3  
1 5 3 . 0 9 2 4 . 4 7  
1 0 9 . 8 9 3 0 . 7 5 
1 2 0 . 1 1 2 7 . 9 1 
1 1 7 . 49 2 5 . 4 5 
1 1 8 . 1 0 2 5 . 0 0 
1 1 8 . 0 5 2 4 . 7 0  
1 3 2 . 3 9 2 5 . 0 5  
1 2 1 . 6 4  2 4 . 2 5  
1 1 6 . 3 1 2 5 . 2 2  
1 1 5 . 4 8 2 4 . 0 4 
tn . 
tn 
RAW DATA TABLE VII ( CONTINUED ) 
F e tu s  RBC
1 
WBC






% g% c y te s 5  uug u 3 % 
Doe 5 
1 2 . 5 7  1 . 4 4 · 3 2 . 0  8 . 3 1 1 . 4  3 2 . 2 9 1 2 4 . 5 1  2 5 . 9 4 
2 3 . 8 5  1 . 7 5  4 3 . 0  1 1 . 5 1 4 . 6  2 9 . 8 3  1 1 1 . 5 4 2 6 . 7 4 
3 3 . 0 6 l ., 8 6  3 6 . 0  8 . 9 2 6 . 9  2 9 . 0 8 1 1 7 . 6 5  2 4 . 7 2 
4 3 . 0 7  1 . 1 9 3 6 . 0  9 . 2  1 3 . 8  2 9 . 9 2 1 1 7 . 0 7  2 5 . 5 5  
5 3 . 5 7  1 . 6 6 4 2 . 0  1 1 . 2  1 4 . 3  3 1 . 3 7  1 1 7 . 6 5  2 6 . 6 7  
Doe 6 
1 3 . 3 9 1 . 6 6  3 8 . 5  1 0 . 7  7 . 9  3 1 . 5 6 1 1 3 . 5 7 2 7 . 7 9 
2 3 . 0 2  1 . 4 0  3 4 . 5  9 . 5 9 . 5 3 1 . 4 0 1 1 4 . 0 5 2 7 . 5 4  
3 3 . 5 0 2 . 8 6  4 1 . 0 1 1 . 0  1 1 . 5  3 1 . 3 8 1 1 6 . 9 7  2 6 . 8 3  
4 3 . 0 1 1 . 8 1  3 5 . 0  9 . 3  8 . 7  3 0 . 8 4 1 1 6 . 0 9 2 6 . 5 7  
5 3 . 2 5  1 . 2 6 3 8 . 0 9 . 9 9 . 7  3 0 . 4 6 1 1 6 . 9 2  2 6 . 0 5  
6 3 . 4 6 1 . 4 7 3 8 . 0  1 0 . 6  1 1 . 3  3 0 . 6 3 1 0 9 . 8 3  2 7 . 8 9 
7 3 . 2 4 0 . 6 3  3 6 . 5  1 0 . 0 1 3 . 2  3 0 . 8 2 1 1 2 . 48 2 7 . 4 0 
Doe 7 
1 2 . 4 1 2 . 1 3  • 3 3 . 0 8 . 8 8 . 2 3 6 . 44 1 3 6 . 6 4 2 6 . 6 7  
2 3 . 3 1 2 . 1 5 4 2 . 0 1 0 . 4  7 . 2 3 1 . 4 2 1 2 6 . 8 9 2 4 . 7 6 
3 3 . 5 0 2 . 4 7  3 9 . 0  1 0 . 6  1 0 . 0  3 0 . 2 8 1 1 1 . 4 3 2 7 . 1 8 
4 3 . 3 7 2 . 3 3 3 9 . 0  1 0 . 0  8 . 4 2 9 . 6 7 1 1 5 . 7 3 2 5 . 6 4 
Vl • 
O'\ 
RAW DATA TABLE VI I ( CONTI NUE D ) 




P CV3 Hb4 Re ticu l o -
% g% c y te s S 
5 3 . 6 9 2 . 1 9 4 4 . 0  1 1 . 6 1 0 . 8  
6 3 . 3 8 2 . 2 6 3 7 . 0 1 0 . 0  7 . 2  
7 3 . 8 3  2 . 4 0  4 1 . 0  1 1 . 0  1 1 . 0 
Me an 
3 . 6 7 2 . 0 5  4 1 . 9  
1 6 3 Re d B l o o d  C e l l s  x 1 0  /mm • 
2





3 P ack e d  Ce l l  Vo lume . 
4
Hemog l ob in . 
1 1 . 1  1 0 . 4  
5 R e t i cu l o c y te s p e r  1 0 0 0  e ry throcy te s . 
6
Me an C o rpu s cu l ar Hemo g l obin . 
7 Me an Corpuscu l ar Vo l ume . 
8
Me an Corpu scu l ar He�og lobin Concen tration . 
MCH6 
uug 
3 1 . 4 4 
2 9 . 5 8 
2 8 . 7 2 




1 1 9 . 2 4 
1 0 9 . 4 7  
1 0 7 . 0 5 




2 6 . 3 6 
2 7 . 0 3  
2 6 . 8 3 
2 6 . 5 5 
U1 
.....,] 








1 5 0 . 0  0 . 6 4  7 . 0 2 
2 4 9 . 1  0 . 6 2  7 . 3 5  
Doe 2 
1 3 9 . 4  0 . 6 6  7 . 2 6 
2 3 1 . 6  0 . 6 5  6 . 3 1  
Doe 3 
1 4 5 . 8  0 . 6 6  8 . 7 5  
2 3 8 . 7  0 . 6 1  7 . 1 6 
3 4 3 . 8  0 . 6 3  7 . 1 8 
4 4 9 . 3  0 . 5 5  7 . 8 3  
Doe .4  
1 3 5 . 2  0 . 6 0 6 . 0·2 
2 3 7 . 4  0 . 6 0  6 . 3 7  
3 3 4 . 8  0 . 5 6  6 . 3 3 
4 2 4 . 7  0 . 5 7 4 . 6 0 
5 2 5 . 5  0 . 6 0 4 . 8 7  
6 3 5 . 6  0 . 6 6  6 . 2 2  
7 3 3 . 8  0 . 6 2  6 . 2 7  
RAW DATA TABLE VI I I  
GROUP I I · FETUS · SAMPLE S 
K i dney 
2 
Lung 
2 RBC Fe 
mg% 
o . s s  0 . 6 0 2 6 . 0 4 
0 . 5 5 0 . 7 7 
0 . 5 3  0 . 9 7  1 1 . 5 3 
0 . 5 7 0 . 8 3  
0 . 5 2  1 . 0 5  3 4 . 5 1 
0 . 5 5  1 . 0 4  
0 . 5 4 0 . 7 7 
0 . 5 1  0 . 8 3  
0 . 5 2  0 . 70 3 5 . 9 5 
0 . 5 5  0 . 8 2  
0 . 5 2  0 . 6 7  
0 . 4 8 0 . 7 7 
0 . 6 0  o • . 8 3  
0 . 5 4  0 . 5 9 
0 . 5 4 0 . 8 2  
P l a s ma F e  RBC Mn P l a sma Mn 
mg% ug% ug% 
0 . 7 5 9  2 1 . 2 5 1 4 . 7 5 
0 . 9 4 1  2 6 . 2 0 1 3 . 8 2  
0 . 78 4  2 7 . 7 3 1 0 . 5 1 
1 . 5 9 9  2 1 . 9 7  1 0 . 8 2  
lTl • 
ro 






1 3 5 . 1  0 . 5 3 
2 4 4 . 0 0 . 4 8 
3 3 8 . 9  o . s o  
4 4 1 . 5  0 . 4 1  
5 4 0 . 5  0 . 5 2 
Doe 6 
1 3 7 . 3  0 . 6 2  
2 4 4 . 5  0 . 6 3  
3 3 8 . 5  0 . 6 4  
4 3 6 . 6  0 . 7 3 
5 3 3 . 6  0 . 7 3 
6 4 3 . 2 0 . 6 2  
7 3 4 . 7  0 . 7 0 
Doe 7 
1 2 5 . 2  0 . 5 5  
2 2 2 . 4  0 . 5 2  
3 2 2 . 8  0 . 6 1  
4 2 3 . 2  0 . 8 0  
RAW DATA TABLE VI II ( CONTINUE D )  





2 RBC Fe P l asma Fe 
mg% mg% 
6 . 6 4  0 . 4 9  0 . 9 5  3 0 . 6 0 0 . 5 3 2  
7 . 2 5 0 . 5 7  0 . 8 6  
7 . 4 1  0 . 6 3  0 . 9 5  
6 . 8 2  0 . 5 4  0 . 9 1  
7 . 5 6 0 . 6 5  0 . 9 8  
6 . 4 9 0 . 5 5  1 . 0 6  2 5 . 6 7 0 . 4 2 6 
6 . 6 1  0 . 4 7 1 . 3 7 
6 . 9 0  . 0 . 5 1 0 . 8 2  
7 . 0 8  0 . 4 3 0 . 68 
6 . 5 8 0 . 5 2  1 . 2 1  
6 . 5 2  0 . 3 9  1 . 1 0  
6 . 2 4  0 . 5 5  1 . 1 1 
5 . 8 9  0 . 4 6  1 . 2 2  3 0 . 2 9 0 . 3 9 3  
5 . 5 6 0 . 4 4 1 . 1 6 
5 . 8 1  0 . 5 7  1 . 1 3 
6 . 3 8 0 . 5 1  0 . 9 5  
RBC Mn 
u g% 
1 5 . 7 4 
1 6 . 1 8 
2 0 . 3 5 
P l a sma Y.m 
ug% 
5 . 9 9 
6 . 3 4 
7 . 1 6 
<.n 
\.0 
RAW DATA TABLE VI I I  ( CONTINUE D ) 
Fe tu s  T BW
1 
H e a r t  
2 






RBC Fe P l a sma Fe 
g mg% mg% 
5 2 4 . 9  0 . 6 3  6 . 0 9  0 . 4 9  0 . 8 8  
6 2 6 . 0  0 . 7 5 6 . 6 5  0 . 4 7  0 . 8 4  
7 2 4 . 6  0 . 6 1  6 . 1 4  0 . 5 1  0 . 9 8  
Me an 
3 5 . 6  0 . 6 1  6 . 5 9 0 . 5 2 0 . 9 2  2 7 . 79 0 . 7 7 6 
1 T o t a l  Bo dy W e i ght . 
2
we i gh t  a s  p e rcentage o f  t o t a l  body we i gh t . 
RBC Mn 
ug% 
2 1 . 3 4 
P l a sma Mn 
ug% 
9 . 9 1  
(j) 
0 
RAW DATA TABLE IX 
GROUP I I I · F E TUS SAMPL E S  
Fe tu s  RBC 1 WBC 2 P C V3 Hb4 Re t i c u l o - MCH6 MCV 7 MCHC 8 
% g% cyte s S  uug u 3 % 
Doe 1 
1 3 . 49 1 . 2 2  3 9 . 0  1 0 . 5  7 . 6 3 0 . 0 8 1 1 1 . 7 5 2 6 . 9 2  
2 4 . 2 7  2 . 0 0  4 8 . 5  1 2 . 8  7 . 1  2 9 . 9 8 1 1 3 . 5 8 2 6 . 3 9 
3 3 . 8 1 1 . 4 7  4 7 . 5  1 2 . 3  8 . 3  3 2 . 2 8 1 2 4 . 6 7 2 5 . 8 9 
4 3 . 9 6  1 . 3 4  4 4 . 0  1 1 . 9  7 . 3  3 0 . 0 1  1 1 0 . 9 7  2 7 . 0 4 
5 4 . 0 6  1 . 5 5  4 6 . 5  1 2 . l  8 . 0 2 9 . 8 0 1 1 4 . 5 3  2 6 . 0 2 
6 3 . 3 6 1 . 4 1  3 8 . 5  1 0 . 7  9 . 5  3 1 . 8 0 1 1 4 . 4 1 2 7 . 7 9 
7 3 . 49 1 . 9 6  4 3 . 0  1 1 . 5  9 . 1 3 2 . 9 0 1 2 3 . 0 3  2 6 . 7 4 
Doe 2 
1 3 . 8 1  1 . 3 0 4 4 . 0  1 1 . 8  8 . 8 3 0 . 9 3  1 1 5 . 3 3 2 6  . 8 2 . 
2 3 . 7 2 2 . 0 7  4 3 . 5  1 2 . 3  1 0 . 2  3 3 . 0 2 1 1 6 . 7 8 2 8 . 2 7  
3 3 . 8 5  2 . 0 9  4 4 . 5  1 2 . 1  9 . 4 3 1 . 4 3 1 1 5 . 5 8 2 7 . 1 9 
4 3 . 7 5 1 . 6 9  4 7 . 0  1 2 . 2  7 . 8 3 2 . 49 1 2 5 . 1 7  2 5 . 9 6 
5 3 . 6 4  1 . 4 6 4 2 . 5  1 1 . 4  7 . 6  3 1 . 3 2 1 1 6 . 7 6 2 6 . 8 2 
6 4 . 0 2  2 . 3 5  48 . 0  1 2 . 5  9 . 5  3 1 . 0 9  1 1 9 . 4 0 2 6 . 0 4 
7 4 . 2 1 2 . 2 9 · 5 0 . 5 1 3 . 1  8 . 2 3 1 . 1 2 1 1 9 . 9 5  2 5 . 9 4 
8 4 . 5 8 1 . 4 6  5 0 . 5  1 3 . 3  1 1 . 2  2 9 . 0 4 1 1 0 . 2 6 2 6 . 3 4 
Doe 3 
1 3 . 2 6  1 . 1 8  3 8 . 0  1 0 . l 1 0 . 4  3 0 . 9 8 1 1 6 . 5 6 2 6 . 5 8 
2 3 . 1 4  1 . 1 5 3 8 . 5  1 0 . 5  1 0 . 4  3 3 . 4 4 1 2 2 . 6 1 2 7 . 2 7  
3 3 . 3 5  1 . 0 9  4 2 . 5  1 1 . 0  9 . 2 3 2 . 7 9 1 2 6 . 6 8 2 5 . 8 8 
4 3 . 2 6  0 . 9 9  3 9 . 5  1 0 . 6  9 . 6 3 2 . 5 1 1 2 1 . 1 6 2 6 . 8 3  
O' 
r' 
RAW DATA TABLE IX ( CONTINUE D )  
F e tu s  RBC 1 W BC 2 P C V3 Hb4 Re t i cu l o - MCH6 MCV7 8 MCHC 
% g% cyte s 5 uug u 3 % 
5 3 . 4 0  1 . 1 0 4 0 . 0  1 0 . 7  9 . 2  3 1 . 4 7 1 1 7 . 6 5 2 6 . 7 5 
6 3 . 2 5 1 . 1 7 3 8 . 5  1 0 . 0  1 0 . 2  3 0 . 7 2 1 1 8 . 2 8 2 5 . 9 7  
7 2 . 9 5  1 . 1 6 3 6 . 5  1 0 . 1  8 . 8 3 4 . 2 4 1 2 3 . 7 3 2 7 . 6 7  
8 3 . 0 0  1 . 0 3  3 8 . 0  1 0 . 7  2 0 . 6  3 5 . 6 7  1 2 6 . 6 7  2 8 . 1 6 
9 3 . 0 4  1 . 5 7  3 5 . 0  1 0 . 1 1 2 . 0  3 3 . 1 7  1 1 4 . 9 4 2 8 . 8 6 
1 0  3 . 0 5  1 . 0 8  3 6 . 5  1 0 . 0  1 0 . 8  3 2 . 7 9 1 1 9 . 6 7  2 7 . 4 0 
Doe 4 
1 3 . 1 8  1 . 0 0  3 5 . 5  1 0 . 0  8 . 1 3 1 . 40 1 1 1 . 4 6 2 8 . 1 7 
2 3 . 1 5  0 . 9 8  3 7 . 0  9 . 6 8 . 4  3 0 . 48 1 1 7 . 4 6 2 5 . 9 4 
3 3 . 1 5  1 . 1 3 3 8 . 0  1 0 . 0  1 0 . 2  3 1 . 6 9 1 2 0 . 4 4 2 6 . 3 1  
4 3 . 4 5  0 . 8 7  4 0  .. 5 1 0 . 6  7 . 0  3 0 . 7 2 1 1 7 . 3 9 2 6 . 1 7  
5 3 . 1 4 0 . 8 5  3 8 . 5  9 . 7 7 . 2 3 0 . 8 9 1 2 2 . 6 1  2 5 . 1 9 
6 3 . 1 2 0 . 7 7 3 5 . 5  9 . 3  1 0 . 1 2 9 . 7 6 1 1 3 . 6 0 2 6 . 2 0 
7 2 . 8 8  0 . 6 3  3 3 . 5  9 . 1 s . o - 3 1 . 6 0  1 1 6 . 3 2 2 7 . 1 6 
8 3 . 0 8  0 . 7 8 3 8 . 0  1 0 . 1  8 . 1 3 2 . 7 4 1 2 3 . 1 8 2 6 . 5 8 
Doe 5 
1 4 . 2 0 1 . 2 0  4 3 . 0  1 2 . 2  8 . 1 2 9 . 0 1  1 0 2 . 2 6 2 8 . 3 7  
2 3 . 8 6  0 . 9 8  3 9 . 5  1 1 . 3  9 . 8 2 9 . 2 4  1 0 2 . 2 0 2 8 . 6 1 
3 3 . 8 8  1 . 5 2  4 2 . 0  1 2 . 4  1 6 . 2  3 1 . 9 6  1 0 8 . 2 5  2 9 . 5 2 
4 3 . 7 7  1 . 0 7  4 0 . 0  1 1 . 1  7 . 9  2 9 . 40 1 0 5 . 9 6 2 7 . 7 5 
5 4 . 2 5  1 . 2 3  4 5 . 0  1 2 . 7  8 . 1 2 9 . 8 5  1 0 5 . 7 6 2 8 . 2 2 
6 3 . 1 1  0 . 9 6  3 5 . 0  9 . 9 8 . 6 3 1 . 8 3  1 1 2 . 5 4 2 8 . 2 8 
7 4 . 0 0 1 . 1 7  4 3 . 5  1 1 . 9  5 . 9 2 9 . 7 1 · 1 0 8 . 6 1 2 7 . 3 6 
CJ) 
(\) 





l 2 . 6 3  1 . 3 0 
2 2 . 6 8 0 . 7 9 
3 2 . 6 3 1 . 5 3 
4 2 . 2 5 1 . 0 0  
5 3 . 2 1  1 .  7 0  
6 3 . 3 8 1 . 8 2  
7 2 . 7 6 1 . 4 0 
8 2 . 4 9  1 . 1 0 
Doe 7 
1 3 . 5 2  1 . 6 3  
2 3 . 7 7 2 . 6 5  
3 2 . 9 1  1 . 7 9 
4 · 4 . 3 2  2 . 8 1 
5 3 . 9 7  3 . 5 1 





R e t icu l o - MC H
6 
% g% cyte s 5 uug 
3 1 . 0  8 . 8 9 . 8 3 3 . 6 5 
3 3 . 0 9 . 1  9 . 2 3 3 . 9 5  
3 2 . 0  8 . 9 7 . 8 3 3 . 9 6 
2 9 . 5  7 . 9  1 3 . 2  3 5 . 0 3  
3 8 . 0 1 0 . 0  1 9 . 1  3 1 . 1 5 
4 1 . 0 1 1 . 3  1 7 . 4 3 3 . 3 8 
3 2 . 5  8 . 8 1 8 . 2  3 2 . 0 6 
2 8 . 0  7 . 8 1 5 . 8  3 1 . 3 2 
3 9 . 5  1 0 . 9 . 8 . 9 3 0 . 9 6 
4 6 . 5  1 2  . 5. 9 . 0 3 3 . 1 6 
3 8 . 0  1 0 . 6 1 2 . 2  3 6 . 4 3 
5 1 . 5  1 3 . 6  1 0 . 1  3 1 . 4 8 





1 1 7 . 8 7  
1 2 3 . 1 3 
1 2 1 . 4 4 
1 3 0 . 8 2  
1 1 8 . 3 8 
1 2 1 . 1 2 
1 1 7 . 7 5 
1 1 2 . 4 5 
112 . 2 1 
1 2 3 . 3 4 
1 3 0 . 5 8 
1 1 9 . 2 1 




2 8 . 5 5 
2 7 . 5 7  
2 7 . 9 7  
2 6 . 7 8 
2 6 . 3 1 
2 7 . 5 6 
2 7 . 2 3 
2 7 . 8 6 
2 7 . 5 9 
2 6 . 8 8 
2 7 . 8 9 
2 6 . 4 1 
2 6 . 2 5 
(J) 
VJ 
RAW DATA TABLE IX ( CONTI NUE D )  












3 . 9 0  
3 . 4 6  
2 . 2 9 
2 . 0 8  
% 
4 4 . 5  
4 3 . 0  
g% cy te s 5 
1 2 . 3  9 . 1 
1 2 . 5  1 5 . 1  
Me an 
3 . 4 7  1 . 4 4 4 0 . 4  
l 6 3 Red B l ood C e l l s  x 1 0  /mm • 
2






P acke d  Ce l l  Vo lume . 
4
Hemog l ob in . 
1 0 . 9  1 0 . 1  
5
Re ticu l ocyte s per 1 0 0 0  e ry throcyte s .  
6
Me an Corpu scu l ar Hemog l obin . 
7 
Me an Corpuscu l ar Vo lume . 
8
Me an C o rpus c u l ar Hemo g l obin Concentra tion . 
uug 
3 1 . 5 0 
3 6 . 1 3 
3 1 . 8 4 
MCV7 
u 3 
1 1 3 . 9 6 
1 2 4 . 2 8 




2, 7 . 6 4 
2 9 . 0 7  
2 7 . 1 4 
(J) 
� 
F e tu s  T BW
1 




1 4 7 . 1  0 . 5 9  
2 4 3 . 0  0 . 5 6  
3 3 8 . 1  0 . 6 4  
4 4 2 . 1  0 . 5 9 
5 3 4 . 3  0 . 6 3  
6 4 2 . 3  0 . 5 3  
7 4 1 . 7  0 . 6 0 
Do e 2 
., 3 1 . l  0 . 5 2 J.. 
2 3 0 . 1  0 . 5 4 
3 3 4 . 5  0 . 5 2  
4 3 1 . 5  0 . 5 3 
5 3 3 . 2  0 . 5 9 
6 3 0 . 1  0 . 6 0 
7 2 4 . 8  0 . 6 3 
8 3 2 . 5  0 . 6 4  
Doe 3 
1 3 2 . 4  0 . 6 2  
2 2 4 . 2  . 0 . 5 6 
3 2 2 . 1  0 . 6 8 
4 2 8 . 0  0 . 6 5  
L i ve r  
2 
6 . 1 3  
5 . 7 7 
6 . 1 9 
6 . 1 7  
5 . 7 1  
5 . 4 0  
5 . 7 8 
5 . 6 3  
5 . 3 4 
6 . 1 5  
5 . 0 5  
5 . 9 8  
5 . 9 6  
4 . 9 r  
6 . 4 4 
5 . 6 9  
4 . 6 3  
4 . 9 9  
RAW DATA TABLE X 
GROUP I I I  F E TUS SAMPLE S 
K i dney 2 Lun g 
2 RBC F e  
mg% 
0 . 5 5  0 . 8 9  3 2 . 2 8 
0 . 5 4  0 . 8 1  
0 . 5 8 0 . 8 4  
0 . 5 9  0 . 6 4  
0 . 5 2 0 . 9 0  
0 . 4 8 0 . 7 7 
0 . 4 8 0 . 7 5 
0 . 4 9 1 . 0 5  2 7 . 2 9 
0 . 4 4  0 . 7 5 
0 . 5 0 0 . 8 8  
0 . 4 5  0 . 9 5  
0 . 5 3  1 . 0 1  
0 . 4 1  0 . 9 9  
0 . 4 4 0 . 8 4  
0 . 4 7  0 . 7 9 
0 . 4 5  1 . 0 2  2 9 . 4 3 
0 . 6 0 1 . 0 2  
0 . 4 5  1 . 0 5  
5 . 6 3  . 0 . 49 1 . 0 6  
P l a sma F e  RBC Mn P l asma Mn 
mg% ug% u g% 
0 . 5 0 4  3 0 . 4 1 7 . 0 6  
I 
0 . 5 0 4  2 8 . 0 7  8 . 3 9  
1 . 0 9 2  2 5 . 4 1 7 . 3 7 
()) . 
(J1 
RAW DATA TABLE X ( CONTINUE D )  
F e tu s  T BW
1 
H e a r t  
2 






RBC F e  P l a sma F e  RBC Mn P l a s ma Mn 
g mg% mg% u g% u g% 
5 2 9 . 3  0 . 6 8  5 . 0 7  0 . 5 5 0 . 7 4 
6 2 6 . 5  0 . 6 2  5 . 2 6  0 . 5 3 1 . 0 2  
7 1 9 . 7  0 . 6 7  4 . 7 6 0 . 5 7  1 . 0 3  
8 3 0 . 6  0 . 6 2  6 . 0 6  0 . 5 4 0 . 7 9 
9 3 0 . 0  0 . 6 0  4 . 7 7 0 . 5 1 0 . 8 8  
1 0  3 4 . 2  0 . 6 2  6 . 3 0 0 . 5 2 0 . 8 9 
Doe 4 
1 4 0 . 3  0 . 4 7  6 . 2 1  0 . 3 4 1 . 1 0  2 5 . 8 1  0 . 3 4 9  1 9 . 1 2 6 . 0 5  
2 3 8 . 6  0 . 4 7  5 . 2 5  0 . 3 8  1 . 0 5  
3 3 3 . 6  0 . 6 4  8 . 1 5  0 . 4 3  1 . 1 3  
4 3 5 . 3 0 . 5 4 5 . 6 4  0 . 4 0  0 . 8 5  
5 3 5 . 4  0 . 5 8 6 . 8 7  0 . 3 8 0 . 9 2  
6 3 9 . 3  0 . 5 5  6 . 4 0 0 . 3 9 0 . 9 0  
7 4 1 . 4  0 . 5 4  6 . 7 7 0 . 3 7  1 . 0 1  
8 4 0 . 8  0 . 6 1 7 . 4 5  0 . 3 8  0 . 6 2  
Doe 5 
1 3 3 . 3 0 . 4 5  6 . 0 2  0 . 4 6  0 . 7 9 3 1 . 7 1 0 . 4 0 1  2 9 . 1 6 9 . 3 1 
2 3 6 . 4  0 . 5 5  6 . 9 2  0 . 4 6  0 . 8 6  
3 3 0 . 8  0 . 5 4 5 . 6 9  o . s o 0 . 8 6 
4 3 4 . 4  0 . 5 9  6 . 3 5  0 . 4 8 0 . 8 4  
5 3 5 . 9  0 . 5 4 6 . 9 0  0 . 5 5  0 . 7 6 
6 3 6 . 9  0 . 5 9 6 . 7 6 0 . 5 1 0 . 9 3  
7 3 2 . 5  0 . 6 5  6 . 9 4  0 . 4 4  1 . 0 0  
"" 
(j) 
RAW DATA TABLE X ( CONTINUE D ) 
F e tu s  TBW
1 
H e a r t  
2 
L i ve r  
2 
K i dney 
2 
Lun g 2 RBC F e  P l asma F e  RBC Mn P l a s ma Mn 
g mg% mg% ug% u g% 
Do e 6 
1 2 2 . 9  0 . 4 6  5 . 5 9 0 . 4 2  1 . 2 6 2 5 . 8 3  0 . 5 0 5  2 6 . 9 5 8 . 85 
2 2 0 . 3 0 . 4 8  6 . 6 1  0 . 4 6  1 . 0 6  
3 1 9 . 7  0 . 4 6  6 . 8 3 0 . 4 4 1 . 1 0 
4 1 0 . 7  0 . 5 3 4 . 5 2 0 . 4 3 1 . 4 7  
5 2 6 . 4  0 . 5 7  8 . 4 0  0 . 48 1 . 1 4 
6 2 8 . 5  0 . 5 3  6 . 9 3 0 . 4 3 0 . 9 6  
7 .  2 4 . 3  0 . 6 3 8 . 1 9 0 . 5 5  1 . 2 0  
8 3 0 . 9  0 . 5 7 8 . 0 6  0 + 4 3 1 . 0 3  
Doe 7 
1 2 6 . 6  0 . 5 3  6 . 1 4  0 . 4 7  0 . 8 1  2 8 . 6 4 0 . 5 5 7  3 0 . 0 9  o . o o  
2 2 3 . 2  0 . 4 7  6 . 1 5  0 . 4 6  0 . 8 7  
3 2 2 . 9 0 . 5 4 6 . 3 0  0 . 4 9  0 . 9 5  
4 2 7 . 1  0 . 6 3  6 . 2 0 0 . 5 1 0 . 9 9  
5 2 5 . 4 0 . 5 5 6 . 1 1 0 . 4 2  0 . 9 5  
6 2 9 . 9  0 . 5 4  6 . 1 3  0 . 5 4 0 . 7 5 
Me an 
3 1 . 3  0 . 5 7  6 . 1 2 0 . 4 7  0 . 9 3  2 8 . 7 1 0 . 5 58 2 7 . 0 3  6 . 7 2 
1
Total Body We i ght . 
2we i g h t  a s  p e rcen tage o f  total body we i gh t . 
O'l 
'1 
6 8  
RAW DATA TABLE X I  
DOE LEUKOCYTE D I F F E REN TIAL 
An i m a l  L y mph o c y te N e u tr o p h i l  Mon ocy te E o s in o p h i l B a s o ph i l  
Group I ( C on tr o l ) P re -t re a tmen t S a mp l e s  
1 1 9 3 5 2 0 0 
2 1 3 1  6 1  3 1 4 
3 1 8 0  1 0  1 0  0 0 
4 1 6 6  2 8  _6 0 0 
5 1 7 2  1 7  1 0  0 1 
6 1 7 3 8 1 6  1 2 
Me an 1 6 9 2 1  8 0 1 
Grou p I I  P r e - t r e a t men t S amp l e s  
1 1 2 0  5 2  1 7  8 3 
2 1 8 1  5 1 0  3 1 
3 1 4 6  3 1  1 4  0 9 
M e an 1 4 9 2 9  1 4  4 4 
Group I I I  P r e - t re a tmen t S amp l e s  
1 1 6 3  1 9  1 1  0 7 
2 1 6 1  2 7  9 1 2 
3 1 4 2  4 2  1 4  2 0 
4 1 4 9  3 8  8 2 3 
Me an 1 5 4  3 1  1 0  1 3 
Group I ( C on t r o l ) :F' i n a l  S amp l e s 
1 1 6 0 3 2  4 l 3 
2 1 6 2  3 0  6 0 2 
3 1 8 0  1 0  1 0  0 0 
4 1 7 0 2 5  5 0 · o 
5 1 4 6  4 8  6 0 0 
Me an 1 6 4  2 9  6 0 1 
Group II .t., in a l  S amp l e s  
1 1 6 0  3 0  7 
1 2 
2 1 7 6 1 6  
4 0 4 
3 1 4 2 4 9  4 2 
3 
Me an 1 5 9  3 2  
5 1 3 
Group I I I  F in a l  S amp l e s  
5 8  1 4  2 
4 
1 1 2 2  l l 
2 1 7 5  1 4  9 
6 9  
RAW DATA TABLE X I  ( CONTINUE D )  
An ima l Lymph o c yte Neutr oph i l  Mon o cyte E osino phil Basoph il 
3 
Mean 
1 2 6  
1 4 1  
5 0  
4 1  
1 8  
1 4  
2 
2 
4 
3 
